rfhg_216105.1

Basic information about the TSS

---

TSS ID: rfhg_216105.1 Species: human Chr: chr19		Start: 54458615 End: 54458646 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000421200.1:-200 GeneID: 114823 HGNC/MGI_ID: HGNC:15500 UniProt_ID: H7BZP5 Nearer transcript ids and distances:

Gene_name: leukocyte receptor cluster member 8 Gene_symbol: LENG8 Gene_synonyms: KIAA1932 MGC40108 pp13842 Gene_source: HGNC:15500

TATA-Box annotation

---

Distance to TSS:	5148
Nearest PromoterID:	NM_001301782
Entrez ID:	94059
Nearest Unigene:	Hs.590976
Nearest Refseq:	NM_198988
Nearest Ensembl:	ENSG00000275183
Gene Name:	leukocyte receptor cluster member 8
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LENG8 p2@LENG8 p3@LENG8 p4@LENG8 p5@LENG8 p6@LENG8 p7@LENG8 p9@LENG8
Sample		p1@LENG8	p2@LENG8	p3@LENG8	p4@LENG8	p5@LENG8	p6@LENG8	p7@LENG8	p9@LENG8
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	95.65	2.14	7.01	1.75	0.78	1.56	1.17	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	91.85	2.83	8.50	1.62	0.81	1.01	1.21	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	92.79	1.16	8.87	3.28	1.74	1.54	2.12	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	105.41	1.25	3.95	2.91	0.83	1.04	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	104.61	1.80	6.30	1.57	0.45	1.35	0.90	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	116.87	0.97	6.78	2.33	1.36	0.97	1.16	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	94.56	1.53	5.66	1.31	1.09	1.74	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	77.51	1.45	3.15	1.21	0.24	0.48	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.02	0.43	3.21	1.50	1.50	0.43	1.28	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	66.08	0.58	2.90	1.74	0.58	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.10	2.02	2.02	3.23	2.83	0.00	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	69.93	0.41	1.22	1.63	0.41	0.81	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	96.07	4.35	12.57	7.74	1.61	1.77	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	95.62	3.01	10.37	6.77	1.65	0.45	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	84.31	3.73	8.12	5.71	2.42	1.54	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.13	2.77	10.06	5.53	2.01	0.75	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	57.66	1.09	6.99	3.93	1.31	0.66	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	43.87	2.11	10.55	3.80	2.11	1.69	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	83.17	6.40	11.20	8.00	1.60	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	82.14	2.71	10.08	6.62	1.50	1.20	1.81	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	80.06	2.27	11.90	6.68	1.74	1.07	2.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	96.84	3.97	14.16	6.56	1.55	0.52	1.55	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	92.03	2.07	10.60	8.01	1.16	0.90	1.29	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	74.98	2.18	18.20	6.31	0.97	0.24	1.70	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	82.81	3.61	16.51	6.19	1.81	1.55	1.81	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	70.27	2.53	12.03	6.33	1.90	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	78.57	1.65	11.54	2.20	1.10	0.00	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	117.88	4.01	10.37	3.54	1.65	1.18	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	77.37	1.78	10.98	5.81	1.29	1.29	1.45	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	86.32	2.90	11.22	4.34	1.27	0.36	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	79.34	3.14	10.68	8.37	1.47	0.63	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	64.28	1.56	12.31	5.67	2.74	1.76	0.78	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	73.65	2.53	19.63	9.71	4.01	1.69	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	100.61	1.98	11.88	7.92	2.31	0.66	2.14	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	67.50	1.68	12.34	6.54	1.50	1.68	0.75	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	62.66	2.11	10.35	4.79	0.96	0.96	0.96	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	62.74	1.43	12.88	4.50	2.25	0.82	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	61.86	2.01	5.04	4.43	0.60	0.60	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	66.99	1.08	7.83	5.13	0.81	1.08	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	62.18	1.92	6.24	3.60	1.20	3.12	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	53.87	2.12	7.53	5.41	0.94	1.18	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.65	1.61	9.08	4.25	1.46	0.88	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	71.28	1.05	10.33	4.01	1.27	0.84	1.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	69.23	1.92	12.76	4.37	1.57	1.05	0.87	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.50	2.81	8.23	2.81	1.61	0.80	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	57.46	1.16	15.35	7.91	3.49	2.09	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.74	1.68	7.92	2.64	1.20	0.48	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.99	2.09	5.96	3.87	0.30	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	54.34	1.44	8.14	4.07	0.72	0.48	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.54	1.42	6.67	1.82	0.61	0.20	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	71.32	1.23	12.09	7.99	0.82	1.23	3.07	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	72.94	1.78	12.68	5.34	2.45	1.56	1.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	13.99	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	68.13	2.13	12.07	3.55	2.48	0.35	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	66.61	2.98	7.62	4.64	1.33	0.99	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	67.11	0.84	31.88	18.46	4.19	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	64.29	0.46	13.32	9.18	2.30	0.92	3.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	67.41	2.59	13.29	2.59	0.65	1.94	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	59.10	2.25	16.38	4.82	1.61	0.32	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	66.32	0.94	14.77	4.09	1.26	0.63	2.20	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	0.71	12.69	2.82	0.00	0.71	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	61.13	1.68	8.97	2.24	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	62.90	0.00	48.56	8.76	3.98	0.80	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	54.36	0.00	11.55	4.08	1.36	1.36	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	79.93	2.92	15.60	3.57	0.65	0.97	2.60	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.79	2.48	13.13	1.42	0.71	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	48.49	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	39.49	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	43.88	1.46	6.83	5.85	1.95	0.98	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	42.64	1.49	3.97	1.98	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.50	2.35	6.57	0.00	1.41	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	53.65	2.32	16.56	3.64	0.99	1.66	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	58.77	4.33	10.52	3.09	1.24	1.86	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	65.12	3.67	7.34	1.53	0.61	1.53	1.83	0.00
Adipocyte - breast, donor1	11376-118A8	58.76	1.43	0.63	2.53	0.63	1.11	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	50.69	1.28	0.48	3.53	1.60	0.64	1.28	0.16
Adipocyte - omental, donor1	11473-119C6	62.72	1.02	1.02	1.27	0.64	0.64	0.25	0.89
Adipocyte - omental, donor2	11474-119C7	25.41	1.49	1.49	1.49	0.00	1.49	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	30.48	1.00	1.00	0.00	0.67	0.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	10.85	1.28	0.00	0.64	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.55	0.90	0.90	0.00	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.29	0.52	0.17	0.17	0.00	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	64.15	2.35	0.20	0.39	0.20	0.59	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	65.12	2.06	1.29	0.51	0.26	0.51	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	42.65	2.23	0.84	0.00	0.00	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	45.26	1.76	1.76	1.18	0.00	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	55.42	1.53	0.40	0.24	0.00	0.16	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	47.77	1.29	1.61	0.65	0.32	0.97	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	47.45	1.07	0.53	3.20	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	30.05	0.56	0.56	0.00	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	38.68	0.42	1.25	0.00	0.00	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	49.48	1.76	1.26	0.25	0.00	0.00	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	36.98	0.33	0.00	0.98	0.33	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	24.05	1.22	1.22	0.00	0.00	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	41.11	0.44	0.00	0.00	0.22	1.10	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	23.67	0.00	0.36	0.00	0.36	0.00	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	34.36	0.36	1.26	0.36	0.18	0.36	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	0.00	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	37.60	0.82	0.21	0.21	0.00	0.21	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	18.65	0.34	0.46	0.00	0.23	0.00	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	16.65	0.24	0.00	0.24	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	29.20	0.45	1.35	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.99	1.74	0.87	0.87	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	0.00	0.00	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.00	0.30	0.60	1.20	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	1.26	1.26	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	1.32	0.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.64	0.97	1.30	0.65	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	31.55	0.00	2.43	0.49	1.46	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	2.38	1.78	0.00	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.75	1.13	0.75	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	0.00	0.00	1.45	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	0.00	0.00	2.51	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.65	0.66	0.33	0.00	0.00	0.33	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.42	1.21	0.45	0.15	0.15	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	25.18	1.07	1.07	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.21	0.94	0.94	0.76	0.19	0.94	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.38	0.00	1.07	0.27	0.27	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	0.00	0.00	1.95	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	25.87	0.33	0.33	0.17	0.17	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	0.00	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.87	1.03	0.86	0.51	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.81	0.97	0.49	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.91	0.76	2.28	0.00	0.00	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	2.42	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.23	0.00	0.57	0.00	0.57	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.51	0.43	0.21	0.00	0.00	0.21	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.68	0.77	0.52	0.77	0.52	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.50	1.41	0.47	0.94	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	0.64	0.00	0.96	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	0.00	0.71	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	1.17	0.58	0.00	0.58	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.88	0.30	0.30	0.60	0.30	0.30	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	0.00	2.38	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.06	0.00	0.51	1.02	0.51	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	25.72	1.53	1.78	0.00	1.02	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.99	0.86	0.43	0.43	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.61	0.85	0.21	0.42	0.00	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.56	0.00	0.58	0.00	0.00	0.00	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	30.23	0.00	3.78	0.94	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.51	1.02	0.34	0.17	0.17	0.00	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	0.00	0.00	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.08	1.72	0.21	0.64	0.43	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	29.48	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	22.60	0.00	0.73	0.00	0.00	0.00	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.08	0.00	0.00	0.46	0.00	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.76	0.76	1.02	0.51	0.00	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.15	0.83	0.00	0.00	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.83	1.22	0.00	0.31	0.31	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.90	0.48	1.43	0.96	0.00	0.96	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.29	0.22	0.44	0.00	0.22	0.67	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	0.00	0.00	1.53	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	1.11	1.11	0.00	0.00	0.55	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	22.24	0.26	0.79	0.26	0.53	0.00	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.35	0.36	1.45	0.00	0.73	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	49.62	1.60	0.61	0.74	0.12	0.25	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	29.95	0.86	0.34	0.17	0.00	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	29.99	1.26	0.42	0.00	0.21	0.00	0.84	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	71.46	0.70	1.05	0.70	0.35	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.00	1.46	0.81	0.65	0.32	0.49	0.97	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	76.37	0.89	0.89	1.04	0.60	0.45	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	161.82	3.44	1.83	2.87	2.87	0.46	2.75	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	133.43	3.51	1.25	1.38	0.88	1.25	1.00	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	119.94	2.50	1.48	1.59	1.14	0.46	1.37	0.46
Basophils, donor1	12241-129G9	153.26	1.05	1.31	1.05	0.26	0.52	0.00	2.88
Basophils, donor2	12242-129H1	274.20	0.36	2.16	1.80	0.36	0.36	0.36	1.44
Basophils, donor3	12243-129H2	153.02	1.76	1.18	0.88	0.44	0.29	0.00	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	28.24	3.02	0.22	0.43	0.00	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	2.29	0.46	0.46	0.00	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	1.88	0.00	0.00	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	31.19	1.25	0.21	0.21	0.00	0.00	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	22.34	1.38	0.23	0.00	0.23	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	52.90	5.04	0.72	0.36	0.36	1.08	1.08	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	166.13	0.82	2.06	1.75	1.34	1.03	0.41	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	247.81	4.19	4.66	4.66	0.93	1.86	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	116.40	0.32	0.32	0.96	0.00	0.32	0.00	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	289.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	258.11	1.13	3.38	0.56	1.13	1.13	0.00	1.69
CD14+ Monocytes, donor2	11305-117B9	285.08	1.86	6.50	1.30	2.04	1.11	3.34	1.11
CD14+ Monocytes, donor3	11381-118B4	256.42	1.54	6.59	2.63	0.00	1.54	2.63	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	112.37	1.42	1.42	1.70	0.00	1.13	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	110.31	0.76	2.27	1.14	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	104.54	1.97	1.31	0.33	0.66	0.99	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	129.08	1.59	2.89	3.04	1.30	0.72	0.72	1.73
CD14+ monocytes - mock treated, donor2	11873-125C1	111.34	1.51	0.30	1.81	0.30	0.60	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	147.11	2.13	3.08	2.61	0.47	0.47	0.71	3.08
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	101.11	1.00	2.18	4.02	0.33	1.00	0.67	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	113.72	0.28	3.04	1.93	0.55	0.28	0.00	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	145.78	0.99	1.49	2.23	0.74	0.25	0.99	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	89.29	1.57	2.74	1.17	1.37	0.20	0.98	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	120.18	1.07	3.38	2.31	0.00	0.89	0.53	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	115.56	0.87	1.31	2.18	0.22	0.65	0.87	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	126.90	0.94	0.94	2.11	0.47	0.00	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	177.42	0.53	3.17	3.70	0.53	0.00	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	180.83	2.22	1.11	1.11	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	102.49	0.15	1.49	4.46	1.04	1.19	1.04	2.23
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	102.97	0.80	1.00	2.20	0.20	0.20	0.40	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	103.89	0.83	0.83	2.29	0.62	0.21	0.42	2.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	125.37	0.46	4.58	2.75	0.00	0.46	1.14	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	142.28	1.36	1.81	2.04	0.00	0.90	0.90	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	154.51	0.44	2.18	3.06	0.44	0.00	1.75	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	84.19	1.34	2.69	0.81	0.54	0.54	0.81	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	128.58	2.27	3.49	1.05	0.70	0.52	0.87	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	117.41	0.42	0.84	1.26	0.00	0.00	2.52	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	122.17	1.10	2.39	2.76	0.73	0.37	1.84	2.76
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	131.04	0.00	2.11	2.11	0.70	0.35	0.70	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	179.44	1.75	2.63	3.51	0.44	0.00	1.75	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	99.57	1.57	2.09	4.53	0.70	1.22	0.17	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	134.92	1.12	2.97	1.49	0.37	1.86	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	161.23	2.16	1.72	1.94	0.43	1.29	0.65	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	143.73	0.41	4.50	4.50	0.41	0.00	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	160.87	1.39	1.16	1.62	0.00	0.00	0.70	3.48
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	122.03	1.16	0.93	1.62	0.46	1.16	0.46	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	105.06	0.44	0.87	2.83	1.09	1.53	0.65	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	143.91	1.39	2.77	0.92	1.62	0.69	1.39	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	96.83	0.65	0.87	2.38	0.43	0.65	0.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	228.13	1.87	2.49	4.98	0.78	1.71	1.25	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	191.93	1.57	1.57	5.24	1.22	1.05	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	269.57	0.67	1.78	2.68	0.22	0.89	0.00	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	130.65	0.26	1.79	1.53	1.02	0.51	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	147.55	1.76	1.10	4.39	1.32	1.10	0.66	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	134.75	1.47	1.47	2.95	1.68	0.84	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	121.94	0.00	0.00	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	183.05	1.36	1.36	2.03	0.00	0.00	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	148.09	2.07	1.04	2.07	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	101.28	1.07	0.53	1.07	0.53	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	191.38	1.07	1.07	3.75	0.00	1.07	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	202.16	0.00	4.21	3.51	0.70	1.40	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	188.25	0.00	0.00	1.57	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	177.97	1.32	1.32	0.00	0.00	0.00	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	448.76	0.82	7.40	4.11	2.47	2.47	5.75	1.64
CD19+ B Cells, donor2	11624-122B4	348.21	0.73	6.53	5.08	2.90	3.63	5.08	2.18
CD19+ B Cells, donor3	11705-123B4	446.27	1.51	4.54	4.54	2.52	0.50	2.52	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	123.64	1.21	1.21	0.81	0.00	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	87.49	1.60	0.40	1.20	0.40	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	191.77	1.00	0.00	3.01	0.00	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	201.69	0.00	0.56	0.56	0.00	1.12	0.00	3.37
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	115.73	0.38	2.63	4.13	0.38	0.75	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	140.70	0.45	0.68	0.68	0.45	0.45	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	540.58	0.71	3.57	3.21	2.50	3.93	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	409.67	0.61	9.80	6.74	7.35	4.29	7.96	3.06
CD4+ T Cells, donor3	11382-118B5	414.49	0.91	6.71	3.05	2.44	2.13	3.96	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	322.62	1.28	2.55	2.04	1.02	1.02	1.28	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	260.08	0.67	3.82	8.09	1.80	1.12	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	306.72	3.16	2.87	10.06	1.15	2.01	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	448.02	0.47	5.69	4.74	2.37	1.42	2.84	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	455.10	0.00	2.11	7.73	2.81	0.00	3.51	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	487.84	0.00	3.30	9.89	3.30	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	194.37	1.01	2.46	4.77	0.87	1.01	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	196.92	3.56	3.56	8.30	1.02	1.19	1.86	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	198.12	1.93	4.19	7.09	2.42	1.29	0.97	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	258.22	0.90	4.48	6.72	4.03	2.24	1.79	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	239.68	0.35	1.05	5.94	3.49	0.35	1.05	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	522.26	3.08	5.72	15.84	2.64	0.44	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	307.38	0.84	1.69	6.32	2.53	1.26	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	162.89	1.87	4.78	7.90	1.66	1.66	1.66	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	159.71	1.67	5.35	9.36	1.67	0.33	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	646.66	1.90	7.07	19.58	4.89	4.08	1.90	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	760.51	0.54	6.97	13.93	2.14	6.43	7.50	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	661.70	0.00	10.76	25.11	7.17	3.59	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	268.87	2.41	2.23	8.34	2.04	1.67	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	167.23	3.47	2.38	3.47	1.30	1.30	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	205.11	1.05	3.15	3.57	1.05	1.05	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	325.10	0.51	0.00	3.54	2.02	2.02	3.03	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	329.27	2.17	2.17	4.33	1.30	1.73	0.43	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	566.56	1.74	6.54	11.77	6.54	3.05	2.61	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	295.93	0.99	1.48	3.46	0.99	1.98	3.46	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	261.26	2.77	0.92	7.39	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	160.52	0.00	0.00	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	295.48	0.00	1.94	3.05	0.28	0.83	1.66	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	327.35	0.74	3.93	4.42	0.74	0.25	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	358.82	0.00	3.08	7.70	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	400.38	0.72	0.72	3.58	1.07	2.15	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	228.52	0.00	2.77	4.15	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	500.59	1.96	3.93	5.24	2.29	2.62	0.33	3.93
CD8+ T Cells, donor2	11307-117C2	404.34	0.75	9.76	9.01	3.38	2.25	8.63	3.38
CD8+ T Cells, donor3	11383-118B6	527.70	1.77	7.83	6.06	3.28	2.27	5.05	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	82.35	0.92	5.28	0.69	0.69	0.69	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	75.97	0.72	4.79	1.44	1.44	1.92	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	84.27	1.09	7.11	2.74	0.55	0.55	1.64	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	116.18	2.40	3.90	0.60	0.60	0.60	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	89.27	1.92	5.04	6.24	0.96	1.20	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	88.91	1.59	2.27	2.05	0.91	0.68	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	79.09	1.30	1.96	1.74	0.43	0.65	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	70.01	0.53	2.63	1.05	1.32	0.79	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	72.70	0.47	2.11	1.41	2.11	0.00	0.94	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	80.30	0.91	3.92	1.81	0.30	0.91	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	76.69	0.29	6.68	2.32	0.58	0.58	2.61	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	84.73	2.13	2.93	1.87	0.53	0.00	2.13	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	98.93	1.75	5.25	1.31	0.44	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	109.30	3.19	4.55	2.28	0.46	0.00	1.37	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	108.90	1.49	9.70	3.73	0.75	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	96.88	2.16	1.08	0.72	0.00	1.80	2.52	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	99.84	2.01	2.59	1.15	0.58	1.73	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	85.56	0.94	2.83	0.71	0.47	1.18	0.94	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	98.87	1.27	1.90	1.27	0.95	0.32	1.90	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	104.26	1.54	1.54	1.23	0.62	0.00	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	80.15	0.32	1.60	0.96	1.28	0.32	2.24	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	88.35	2.68	1.53	3.06	1.15	0.76	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	78.43	2.76	2.36	0.39	0.00	1.18	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	74.13	0.00	2.27	3.78	0.00	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	159.79	0.80	3.21	1.61	3.21	0.80	2.41	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	187.45	3.50	10.49	4.90	0.70	2.10	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	234.41	1.00	1.00	4.01	0.00	4.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	118.80	7.31	12.79	1.83	0.00	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	27.67	0.49	0.00	0.49	0.00	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	12.52	0.53	0.11	0.11	0.00	0.11	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	39.52	2.08	2.77	3.12	1.39	0.69	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	20.26	0.00	0.00	0.36	0.00	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	56.78	1.37	2.84	1.14	0.68	1.02	0.46	0.00
Chondrocyte - re diff, donor2	11339-117F7	43.87	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	71.58	1.21	1.21	0.81	0.00	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	92.15	1.61	1.49	0.57	0.23	0.57	0.57	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	63.92	1.50	0.86	0.86	0.86	0.00	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	80.36	2.57	1.95	0.80	0.53	0.44	0.62	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	214.58	5.50	1.56	0.55	1.01	0.64	0.64	1.38
Corneal Epithelial Cells, donor1	11526-119I5	40.84	0.88	0.44	0.22	0.00	0.22	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	31.85	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.42	0.77	0.77	0.26	0.00	0.00	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	53.16	0.66	1.65	0.99	0.83	0.50	0.17	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	51.73	0.95	0.95	0.00	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	59.72	1.94	1.30	1.08	0.54	0.43	0.43	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	434.57	0.68	3.42	4.10	1.71	2.73	1.37	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	289.87	0.65	0.65	0.65	0.00	0.00	0.00	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	316.98	1.45	1.45	3.39	0.00	0.00	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	34.69	0.00	0.00	0.33	0.00	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	22.88	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	36.76	0.57	0.28	0.28	0.28	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	26.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	41.30	0.58	0.29	0.00	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	46.82	1.18	0.47	2.59	0.24	0.94	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	36.11	0.18	0.18	0.00	0.18	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	68.27	1.77	0.44	0.89	0.22	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	72.42	2.43	1.52	0.61	0.91	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	84.57	2.26	0.56	0.56	0.56	1.41	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	39.82	1.49	1.19	2.08	0.89	0.00	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	30.20	0.52	0.00	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	55.44	1.28	0.43	1.28	0.43	0.00	0.14	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	68.82	2.40	2.00	0.40	0.40	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	47.17	0.00	1.05	0.00	0.52	0.00	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	110.46	0.62	0.87	1.86	0.50	0.37	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	75.61	2.61	2.17	0.65	0.43	0.43	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	69.37	0.49	0.98	0.61	0.24	0.24	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	47.78	2.28	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	60.77	2.10	0.00	0.00	0.00	0.00	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	30.93	0.63	0.31	0.16	0.47	0.00	0.31	0.00
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	315.20	0.00	4.95	3.30	0.00	0.00	0.00	6.60
Eosinophils, donor3	12246-129H5	192.61	0.00	0.00	0.00	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.19	1.47	0.49	0.00	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	48.85	3.69	2.05	2.05	0.82	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.61	0.33	0.66	0.33	0.00	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.02	0.11	0.76	0.22	0.00	0.11	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.36	1.21	1.21	0.49	0.49	0.12	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	548.21	12.01	7.78	11.46	2.59	4.37	1.23	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.38	0.53	0.95	0.95	0.21	0.11	0.21	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	198.14	6.32	6.85	3.43	1.84	2.11	1.84	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.81	1.33	0.66	0.66	0.00	0.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	18.60	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	50.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	49.52	1.26	0.79	0.63	0.16	0.47	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	77.90	3.03	0.91	0.30	0.61	0.61	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	39.97	1.02	0.89	0.63	0.38	0.38	1.14	0.00
Fibroblast - Cardiac, donor6	11460-119B2	41.84	1.06	0.76	0.45	0.45	0.15	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.91	2.14	0.54	0.13	0.27	0.13	0.13	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	36.24	1.29	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	2.93	1.46	0.00	4.39	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	29.98	0.46	0.23	0.23	0.00	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	76.15	2.54	1.19	0.68	1.02	1.02	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	63.39	3.29	2.35	0.70	0.23	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	35.85	1.42	0.47	0.94	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	47.63	1.33	1.93	1.21	0.24	0.36	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	39.11	0.79	0.23	0.11	0.11	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	38.38	0.87	0.70	0.35	0.00	0.00	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	45.64	0.65	1.14	1.30	0.00	0.00	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	64.76	1.67	0.42	0.42	0.62	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	72.31	3.41	1.57	1.57	0.26	0.26	1.83	0.79
Fibroblast - Gingival, donor2	11318-117D4	45.86	0.79	1.19	0.26	0.26	0.92	1.19	0.26
Fibroblast - Gingival, donor3	11394-118C8	51.05	3.67	0.29	0.87	0.19	0.29	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	0.00	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.90	0.70	1.06	0.70	0.00	0.18	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.34	1.56	0.78	0.47	0.47	0.47	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	49.90	0.95	0.81	0.68	0.68	0.41	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	71.99	1.76	1.41	1.41	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	48.99	2.19	1.17	1.17	0.44	0.15	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.86	1.50	1.23	0.27	0.00	0.00	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	33.68	0.44	0.55	0.22	0.44	0.00	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	64.12	1.32	2.79	1.47	0.59	0.00	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	32.62	1.36	0.00	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	70.13	0.00	4.48	1.49	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	43.90	1.48	0.42	0.63	0.42	0.21	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	1.67	2.50	0.83	0.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.07	0.28	0.00	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	62.93	2.44	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	3.99	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	64.01	0.39	0.78	0.78	0.78	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.57	0.76	0.61	1.67	0.76	0.00	1.37	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	66.71	1.53	0.00	0.31	0.00	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.78	0.76	0.00	0.76	0.00	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	37.80	1.08	0.27	0.27	1.08	0.27	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.76	0.23	0.81	0.23	0.12	0.12	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.12	0.33	0.33	0.11	0.11	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.83	0.61	0.20	0.61	0.20	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	35.19	1.58	0.00	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	243.89	6.15	10.52	5.56	2.98	3.18	1.59	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	68.74	1.60	1.07	1.07	0.89	0.18	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	72.92	1.77	1.38	1.58	0.59	0.79	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	218.12	4.51	4.81	4.21	3.31	1.50	1.20	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	60.67	1.30	0.97	0.76	0.22	0.22	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	335.58	10.88	8.86	4.81	3.80	1.27	2.02	0.25
Fibroblast - skin normal, donor1	11553-120C5	68.26	1.80	0.98	0.66	0.82	0.66	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	381.16	7.42	3.21	12.43	3.01	2.61	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	55.25	0.90	1.41	0.40	0.20	0.30	0.20	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	311.30	5.44	9.67	4.84	4.23	2.42	3.63	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	66.28	1.41	0.91	0.58	0.41	0.83	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	81.20	1.88	1.20	1.20	0.85	0.51	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	243.37	5.25	7.23	2.63	1.64	2.96	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	46.76	0.32	0.64	0.32	0.53	0.32	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	42.84	0.34	0.67	0.34	0.17	0.51	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.06	0.00	1.41	0.16	0.16	0.16	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	44.32	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	180.41	3.49	6.97	7.84	0.00	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.23	1.73	1.21	1.21	0.00	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	60.38	3.12	0.78	2.86	0.26	1.30	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	53.15	2.81	0.51	1.53	0.00	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	34.45	0.00	0.77	3.06	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	42.75	0.00	1.91	1.28	0.00	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	70.46	0.57	6.28	1.71	0.57	0.57	1.43	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	139.26	1.65	29.78	4.96	0.83	1.65	1.38	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	158.46	2.74	14.16	3.65	1.14	0.23	0.91	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	70.34	2.77	8.52	0.59	0.59	0.40	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	128.20	1.85	27.23	2.64	1.32	2.11	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	192.43	1.96	11.42	3.26	0.98	0.33	1.63	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	60.58	0.88	7.52	2.65	0.88	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	93.41	3.82	1.84	0.99	0.85	0.28	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	86.32	3.82	1.85	1.60	0.86	0.37	0.86	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	59.37	2.42	1.34	1.07	0.27	1.07	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	95.40	3.35	3.22	1.61	0.87	0.37	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	85.27	2.77	1.25	1.38	1.11	0.69	1.25	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	70.34	2.85	2.24	0.41	1.42	0.41	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	97.66	4.34	2.05	1.14	1.60	0.91	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	92.43	4.61	1.49	0.37	0.50	0.37	0.75	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	97.05	5.46	2.19	1.09	0.44	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	111.10	3.84	2.07	0.89	1.48	0.59	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	106.03	1.91	2.54	0.95	1.43	0.64	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	74.62	4.47	1.56	1.12	0.67	0.45	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	97.99	2.02	3.02	0.81	1.61	0.81	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	96.53	2.37	1.53	0.34	1.19	0.51	1.19	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	119.35	3.28	1.06	1.51	0.62	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	204.78	4.27	2.60	8.22	0.21	0.21	0.21	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	182.39	2.22	0.85	6.32	0.17	0.51	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	110.88	2.32	1.77	0.66	0.55	0.77	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	118.55	3.66	1.08	1.08	0.33	1.33	0.25	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	111.28	3.88	1.02	0.82	0.20	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	104.18	1.65	2.06	1.24	1.03	1.03	0.41	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	111.83	2.19	3.46	1.73	0.81	1.27	0.35	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	127.91	2.67	2.84	0.50	1.00	1.67	1.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	101.40	1.54	4.19	1.32	0.44	0.66	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	118.44	3.07	2.58	1.23	0.61	0.86	1.60	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	121.25	3.40	1.95	1.62	0.81	1.46	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	124.76	4.17	4.17	1.60	0.00	0.64	1.60	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	83.95	1.71	1.80	0.57	0.76	0.28	0.38	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	80.99	2.53	1.11	1.42	0.47	1.27	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	84.23	1.82	1.82	1.52	1.52	0.30	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	91.68	1.67	2.40	1.05	0.52	0.84	0.63	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	89.58	3.29	1.54	0.66	0.66	1.32	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	84.45	2.52	3.93	1.68	1.68	0.28	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	99.72	3.06	1.30	1.30	0.37	0.19	0.37	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.69	2.14	1.87	0.80	0.27	0.80	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.97	1.07	1.07	0.77	0.77	0.61	0.15	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	61.92	1.42	1.30	0.13	0.65	0.39	0.26	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	67.50	3.25	0.54	1.36	0.27	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	91.44	3.13	3.50	1.29	1.29	0.92	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	90.80	3.29	2.19	0.44	1.10	1.54	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	144.79	4.96	2.98	3.97	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	91.02	2.37	1.71	1.45	1.06	0.66	0.40	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	74.85	2.42	1.01	1.82	0.81	0.20	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	136.48	3.81	1.78	0.76	0.00	0.00	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	68.28	4.38	1.00	1.19	1.19	0.40	0.80	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	119.10	7.40	2.62	0.92	0.77	0.77	1.39	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	105.16	3.48	2.66	0.61	0.20	0.82	0.61	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	25.97	1.56	0.00	0.00	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.21	0.00	1.13	0.28	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.43	4.61	2.77	2.31	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	2.47	2.47	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	38.68	1.55	1.16	0.77	0.39	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	3.21	0.00	0.00	1.60	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	3.48	3.48	1.74	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.62	1.63	1.63	1.30	0.33	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.83	0.82	3.29	1.65	0.41	0.41	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	0.00	13.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.63	1.40	1.40	0.84	0.84	0.00	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.11	0.98	1.63	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	3.36	12.58	3.36	0.00	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	50.57	2.23	1.59	0.64	0.95	0.32	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.06	0.00	2.72	0.34	0.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	4.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	2.29	2.29	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.65	2.66	1.48	0.59	0.00	0.00	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	0.00	3.39	1.69	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	41.01	0.83	0.83	0.83	0.00	0.41	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	34.75	1.61	0.46	0.69	0.23	0.00	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	15.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	34.60	0.77	2.69	1.15	0.38	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.03	1.63	2.28	0.00	0.33	0.33	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.74	0.00	0.00	0.67	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.95	2.31	1.93	1.16	1.16	1.16	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.24	2.05	2.40	2.05	0.00	1.03	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	2.48	12.42	2.48	0.00	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	52.85	1.89	4.25	0.94	0.47	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	40.43	0.60	1.81	1.21	0.60	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	67.65	1.02	3.56	1.02	0.00	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	53.05	0.80	3.19	1.20	1.20	0.40	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	60.68	0.49	0.99	0.99	0.99	0.49	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	107.42	10.62	5.90	12.98	4.72	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.84	0.00	3.50	1.75	2.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	87.34	2.63	4.39	2.19	1.76	0.88	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	3.39	0.85	2.54	1.70	1.70	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	0.60	1.79	2.98	0.60	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.51	0.97	0.00	0.00	0.49	0.49	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.56	2.08	0.83	4.16	0.00	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	42.73	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	137.33	11.42	0.95	2.22	1.27	1.90	1.90	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.91	3.76	1.25	0.84	0.42	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.34	0.46	1.28	0.12	0.12	0.35	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.99	0.51	0.84	0.51	0.17	0.34	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.80	0.46	1.14	0.00	0.00	0.23	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.90	1.31	1.09	0.66	0.33	0.44	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.39	0.86	0.43	0.21	0.21	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	30.57	0.43	0.22	1.08	0.43	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	43.09	1.00	0.50	0.37	0.62	0.62	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	42.89	1.20	1.54	0.69	1.03	0.34	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.37	1.28	0.32	0.32	0.64	0.00	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	0.56	0.00	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	26.83	1.30	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	40.56	1.06	0.35	0.71	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.86	0.00	0.73	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	16.61	0.35	0.52	0.17	0.00	0.35	0.17	0.17
Hepatocyte, donor1	11523-119I2	67.79	2.42	2.42	2.42	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	84.03	0.00	4.31	2.15	1.08	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	82.83	0.61	4.91	2.45	1.84	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	196.46	3.26	3.92	3.26	1.31	0.65	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	90.01	1.05	0.87	1.05	0.87	0.87	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.99	0.69	0.82	0.14	0.55	0.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	89.15	3.18	0.00	0.00	0.00	0.00	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	88.60	2.77	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	80.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	151.21	5.13	0.00	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	109.70	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	126.70	6.50	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	83.37	1.67	1.67	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	144.26	5.29	1.32	0.00	0.00	1.32	1.32	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	72.06	3.33	1.11	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	130.96	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	105.19	4.41	0.63	0.00	0.00	0.00	1.26	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	78.88	3.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	132.44	2.58	0.00	0.65	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	119.13	6.44	0.00	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00	0.00	0.00	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	135.27	5.70	0.00	0.81	0.81	0.81	3.26	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	114.19	2.94	0.42	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	100.46	3.21	0.00	0.80	0.00	0.00	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	67.40	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	59.00	3.30	0.47	0.94	0.00	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	57.14	2.72	0.00	1.81	0.00	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	106.54	7.53	0.00	0.00	0.00	0.00	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	99.10	5.08	0.00	0.00	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	130.72	5.74	1.28	0.00	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	94.78	1.82	0.00	0.00	0.00	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	132.82	5.71	1.43	0.71	0.00	2.86	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	102.87	9.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	65.44	3.40	0.31	1.23	0.62	0.00	1.85	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	117.65	8.78	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	97.44	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	118.22	4.87	0.00	2.09	0.00	0.70	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	99.59	0.00	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	138.64	7.85	0.00	0.00	0.87	0.00	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	112.49	2.25	0.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	128.93	6.97	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	123.75	5.33	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	87.28	1.39	0.00	0.00	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	88.34	2.85	0.00	0.00	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	118.73	5.52	0.92	5.52	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	148.24	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	0.00	0.00	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	145.92	1.06	1.06	0.00	1.06	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	72.30	5.63	1.47	1.39	0.41	0.24	0.24	0.00
Keratinocyte - epidermal, donor2	11349-117G8	29.87	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.83	2.65	1.23	0.76	0.57	0.47	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	60.73	3.41	0.57	0.57	0.34	0.79	0.23	0.11
Keratocytes, donor1	11527-119I6	37.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	36.33	0.00	0.00	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	19.96	1.19	0.59	0.59	0.20	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	105.50	6.59	6.59	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	32.36	1.08	1.08	0.00	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	53.86	1.27	0.23	0.69	0.46	0.35	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	21.80	0.91	0.10	0.20	0.20	0.00	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.24	0.36	0.12	0.00	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	20.09	0.28	0.84	0.00	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.44	0.63	0.47	0.16	0.16	0.79	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	1.08	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.95	0.00	0.95	0.32	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.05	0.32	0.86	0.11	0.00	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.52	0.41	0.00	0.00	0.00	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	0.51	0.51	0.00	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	30.82	0.70	0.99	0.14	0.56	0.42	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	24.62	0.19	0.97	0.19	0.00	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.29	0.74	0.74	0.00	0.19	0.00	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.78	0.35	0.00	0.70	0.35	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	24.33	0.24	0.24	0.24	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.49	0.41	0.41	0.55	0.00	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.17	1.23	0.31	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	17.46	0.00	0.62	0.31	0.00	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.64	0.37	0.37	0.18	0.00	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.73	0.00	1.97	0.00	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	24.89	0.00	0.29	0.00	0.29	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.15	0.25	0.00	0.25	0.25	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.79	0.00	2.42	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.31	0.54	0.54	0.54	0.00	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	25.58	0.15	0.61	0.30	0.15	0.00	0.15	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.63	0.00	0.52	0.00	0.00	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	0.21	0.84	0.21	0.00	0.21	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.81	0.30	0.60	0.30	0.15	0.00	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	1.38	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.88	0.38	0.00	0.00	0.00	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.18	0.95	0.11	0.11	0.00	0.42	0.21	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	0.97	0.97	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.18	0.00	0.66	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.67	0.87	0.87	0.50	0.00	0.25	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	38.87	0.37	0.74	0.37	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	0.25	0.00	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.05	0.41	0.27	0.14	0.00	0.27	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.02	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	32.56	0.61	0.30	0.00	0.30	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.51	0.42	0.28	0.00	0.28	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.42	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.23	0.31	0.16	0.00	0.00	0.47	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	0.36	0.00	0.00	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.54	0.00	0.65	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.89	0.24	0.47	0.47	0.00	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	24.50	0.62	0.62	0.12	0.12	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.03	0.00	0.77	0.00	0.26	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.01	0.30	0.00	0.00	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.15	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	0.00	0.00	0.00	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.08	2.54	1.27	0.85	0.00	0.00	0.85	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.01	4.22	0.00	1.41	0.70	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	1.87	0.00	0.00	0.00	0.00	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	44.31	0.52	0.00	0.52	1.03	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	3.57	0.00	0.00	0.00	0.00	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	43.43	1.58	0.00	0.23	0.45	0.00	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.32	1.45	1.16	0.58	0.58	0.58	0.58	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	33.76	0.90	0.45	1.80	0.45	0.45	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.05	0.95	0.68	0.81	0.27	0.14	0.14	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.14	2.05	1.03	1.03	0.00	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.70	2.47	1.06	0.35	0.00	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	0.67	1.33	2.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	49.92	2.04	0.00	0.51	1.53	1.02	0.00	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.35	1.07	1.07	1.33	0.27	0.80	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.06	1.70	0.76	0.57	0.57	0.38	1.13	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	52.77	1.84	1.23	1.23	0.00	0.00	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	41.59	1.63	0.82	0.82	0.00	0.00	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.98	0.83	1.25	0.21	0.62	0.21	0.21	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.31	1.12	1.12	1.68	1.40	1.12	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	44.30	1.03	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.32	1.16	1.16	2.03	0.29	0.29	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.91	0.90	0.60	0.30	0.00	0.00	0.30	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	1.66	1.66	2.21	0.55	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	51.96	2.47	1.06	0.71	0.00	1.06	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	37.25	0.00	0.74	0.37	0.37	0.74	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	39.91	2.30	0.38	1.54	0.38	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.84	0.00	1.13	0.57	0.00	1.13	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	1.64	0.82	0.00	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	34.34	2.71	0.90	0.00	0.45	0.00	0.45	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.75	1.44	1.44	0.72	0.00	0.72	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	0.75	0.75	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.04	0.37	1.11	0.37	0.00	0.00	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.98	1.29	0.00	0.00	0.43	0.43	0.00	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	1.71	1.71	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.32	2.33	0.33	1.00	1.00	0.67	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.15	2.41	0.00	1.21	0.00	1.81	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.75	4.27	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	35.06	2.75	1.72	0.69	0.69	0.00	0.34	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.69	1.07	0.00	0.54	0.00	0.00	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	2.02	0.00	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.52	2.96	0.74	0.74	0.74	0.37	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	1.16	0.00	0.00	0.00	0.00	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	1.06	1.06	0.00	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	35.21	2.00	1.60	0.40	1.20	0.00	1.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	51.61	2.18	1.45	0.00	0.00	0.00	0.73	5.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.89	3.83	0.77	0.77	0.00	0.00	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	61.66	3.45	0.99	0.00	0.99	0.00	1.48	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	46.11	9.41	0.00	2.82	0.94	0.00	0.94	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	50.28	2.01	0.50	0.00	0.00	0.50	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.47	5.41	1.35	0.45	0.00	0.45	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	41.31	0.00	1.72	0.00	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	58.79	3.56	1.34	0.45	0.00	0.45	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	59.04	1.56	0.78	1.96	1.56	0.78	0.39	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.08	3.30	0.66	0.00	1.32	0.00	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	51.89	1.04	1.04	1.04	0.00	0.00	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	75.70	3.06	1.75	0.44	0.44	0.44	3.06	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	51.44	3.35	0.56	0.56	0.56	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	49.02	4.42	0.00	0.88	0.44	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	46.67	2.31	1.54	0.77	0.00	1.16	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.04	1.01	0.51	1.52	0.51	0.51	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	44.70	2.40	0.00	0.00	0.48	0.96	0.48	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.98	2.78	0.00	1.19	0.40	0.40	0.80	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	32.20	0.61	1.82	0.00	0.00	0.00	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	27.67	2.08	0.69	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	55.48	4.94	1.14	1.52	0.38	0.38	1.14	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.41	3.61	0.52	1.55	0.00	0.00	0.00	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	35.67	2.42	1.21	0.00	1.21	0.00	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	38.35	1.58	0.95	1.27	0.32	0.95	1.27	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	47.98	1.60	0.00	0.00	0.53	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.05	3.45	0.57	1.15	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	55.54	3.09	2.06	1.54	1.03	1.54	0.51	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	37.49	2.12	1.41	0.71	0.71	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	42.56	2.84	0.00	0.00	0.57	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	43.68	2.08	0.42	1.25	0.00	0.00	2.08	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.85	0.00	0.78	0.78	0.78	1.57	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.06	2.92	0.42	1.25	0.00	0.00	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.03	2.32	0.00	0.46	0.46	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	2.01	0.67	0.67	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	27.27	1.60	0.53	1.07	0.00	0.00	0.53	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	45.66	1.21	0.81	0.00	1.21	0.81	1.21	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	41.30	3.67	0.00	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	21.34	2.67	0.89	0.89	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	38.75	2.28	0.00	0.57	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	1.53	0.77	0.00	0.77	0.00	0.77	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	4.92	1.09	0.55	0.55	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	31.63	0.45	0.00	0.45	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	31.45	4.16	0.52	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.22	2.65	0.66	0.00	0.66	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	2.08	0.00	2.08	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	67.92	1.82	0.68	1.37	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	39.09	0.92	0.73	0.92	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	50.07	1.05	0.79	0.39	0.13	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	1.59	0.00	0.00	0.00	0.53	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	61.16	1.74	0.63	0.16	0.32	0.16	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	48.51	1.11	0.00	0.56	0.42	0.28	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	34.58	1.89	0.50	0.40	0.10	0.20	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	36.19	2.90	0.58	0.29	0.00	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	22.20	1.00	0.00	0.25	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	187.79	0.68	0.00	4.75	0.00	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	128.25	0.76	2.49	2.16	0.65	0.65	0.11	0.22
Mast cell, donor2	11565-120D8	273.70	0.59	3.57	2.67	0.59	0.59	0.00	0.89
Mast cell, donor3	11566-120D9	466.91	2.03	7.20	7.20	0.68	2.70	0.90	1.13
Mast cell, donor4	11567-120E1	293.06	0.71	4.08	1.24	0.53	0.53	0.35	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	230.10	1.00	4.88	3.77	1.44	1.22	0.89	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	184.44	0.58	7.00	1.75	2.33	2.92	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	171.62	0.80	2.29	2.64	1.15	0.69	1.03	0.34
Mast cell, expanded, donor8	11941-126A6	211.38	1.34	5.19	2.01	1.84	0.84	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	28.06	0.60	0.70	0.50	0.10	0.50	0.00	0.40
Melanocyte - dark, donor2	11582-120F7	24.92	0.69	0.35	0.35	0.00	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	75.85	2.17	0.94	0.80	0.29	1.01	0.22	0.36
Melanocyte - light, donor1	11274-116H5	35.97	2.35	0.00	0.24	0.00	0.00	0.24	0.24
Melanocyte - light, donor2	11351-117H1	32.08	1.36	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	26.02	1.73	0.87	0.00	0.00	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	87.67	0.94	1.35	0.83	0.42	0.10	0.31	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	36.31	0.54	0.27	0.27	0.27	0.81	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	71.52	1.61	2.68	1.07	0.80	0.54	0.80	0.80
Meningeal Cells, donor1	11493-119E8	50.24	0.25	0.25	0.37	0.37	0.25	0.00	0.00
Meningeal Cells, donor2	11573-120E7	41.37	0.44	0.00	0.44	0.44	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	45.89	0.49	0.24	0.24	0.08	0.49	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.51	2.00	0.29	0.29	0.57	0.86	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	78.49	1.51	1.11	2.21	0.60	0.40	0.20	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	38.11	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	36.60	0.00	2.87	0.72	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.18	0.64	0.42	0.64	0.00	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	30.16	0.50	2.51	0.50	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	40.00	0.88	0.44	0.22	0.44	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.76	1.46	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	36.42	0.82	0.20	0.41	0.20	0.61	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	52.91	1.66	0.42	0.42	0.69	0.55	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	42.00	1.12	0.37	1.49	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.45	2.37	0.92	0.39	0.53	0.53	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	30.86	0.00	0.00	0.30	0.30	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.30	0.64	0.00	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.84	0.35	1.06	0.71	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	58.79	1.56	0.94	0.31	0.00	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	34.11	2.18	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	69.21	2.12	1.59	0.80	0.00	1.06	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	22.52	0.00	0.00	0.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	50.15	1.95	1.45	2.24	0.07	0.36	0.29	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	49.96	1.35	1.35	2.70	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.53	0.74	0.74	1.48	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	52.71	0.88	0.88	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.57	0.93	0.93	0.00	0.00	0.00	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.24	0.41	0.62	0.62	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.54	1.00	0.75	0.50	0.00	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	57.72	0.93	2.33	0.47	0.47	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.74	0.81	0.20	1.02	0.00	0.20	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	40.78	2.38	0.00	0.00	1.19	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	0.00	1.77	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	38.75	0.76	0.76	0.00	0.38	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	38.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.62	0.64	0.21	0.85	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	25.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.76	0.00	0.30	0.60	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	1.68	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.33	1.00	0.75	1.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	25.91	1.19	0.48	0.00	0.24	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	0.00	0.55	0.00	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	24.87	0.00	0.46	1.15	0.46	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.92	0.21	0.00	0.21	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.83	0.61	0.00	1.02	0.00	0.20	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.60	0.43	0.21	1.50	0.00	0.43	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.34	0.89	0.67	0.22	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	20.15	0.66	0.44	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.87	1.01	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	4.97	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.19	0.82	0.00	0.54	0.00	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.76	0.88	0.29	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	0.00	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.02	0.80	0.80	0.00	0.40	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	0.00	0.00	0.00	0.00	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	0.44	0.44	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.10	0.00	1.28	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.06	0.74	0.00	0.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	0.00	0.00	0.00	0.00	0.00	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	0.00	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	0.00	0.68	0.00	0.00	1.03	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	0.88	0.88	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	27.34	0.36	1.42	0.36	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	32.26	1.68	0.00	1.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.52	0.00	0.42	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	31.47	0.58	0.00	0.58	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.04	0.90	0.30	0.60	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.73	0.42	1.25	0.00	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	31.40	0.92	0.00	0.00	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.73	0.57	0.00	0.57	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.85	0.41	0.14	0.14	0.00	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.39	1.30	0.26	0.00	0.52	0.00	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.17	0.86	1.72	0.86	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	26.68	0.64	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.22	1.07	0.00	0.00	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.62	0.90	0.60	0.30	0.00	0.60	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.93	0.57	0.28	0.42	0.14	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	25.16	0.64	0.64	1.27	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	29.41	1.33	0.44	0.44	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	0.38	0.00	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	32.39	1.14	0.28	0.57	0.57	0.00	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.62	0.74	0.00	0.49	0.00	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	45.62	1.30	0.65	0.00	0.00	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.29	1.76	0.29	0.29	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.62	1.44	0.29	0.29	0.58	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.15	2.89	0.82	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	36.93	1.19	0.30	0.00	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	3.77	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	27.27	0.33	0.99	0.99	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	27.35	0.00	1.05	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.07	0.40	0.99	0.59	0.20	0.40	0.00	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	35.39	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.41	0.38	1.50	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.51	0.80	0.27	0.80	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.92	0.11	0.11	0.11	0.00	0.11	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	0.00	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	0.73	0.37	0.73	0.00	0.37	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	0.00	1.56	4.67	6.22	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	38.48	0.00	0.00	0.53	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	23.23	0.00	2.02	1.01	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	27.41	0.84	1.26	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	58.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	27.34	0.00	0.00	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.91	0.00	0.00	0.00	0.00	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	30.21	0.00	1.51	1.51	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	0.00	0.00	0.00	0.00	0.00	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.24	0.86	0.22	0.22	0.00	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	1.05	1.05	1.57	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	0.67	4.00	0.00	0.00	0.00	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.03	1.67	1.67	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	33.66	0.19	3.80	0.95	0.00	0.38	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	3.19	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.04	4.08	2.04	0.68	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	5.51	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	2.93	4.60	0.00	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.45	0.93	1.63	0.70	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.91	1.35	2.16	0.54	0.27	0.00	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	43.94	1.68	0.84	0.63	0.21	0.21	0.21	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.73	1.99	1.49	0.50	1.49	0.50	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.53	1.62	3.79	1.35	1.62	0.54	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.56	3.40	2.27	0.68	0.23	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.86	1.31	1.80	0.49	0.16	0.16	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.75	1.09	0.73	0.00	0.18	0.18	1.09	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	46.68	5.30	2.65	1.59	0.53	0.53	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	45.62	4.20	3.00	1.20	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.38	0.33	6.56	1.97	1.31	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.66	3.09	3.42	0.98	0.65	0.16	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	43.04	0.35	1.23	0.18	0.00	0.18	0.00	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.76	7.03	2.81	0.70	0.00	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	31.26	0.92	3.68	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.85	1.93	1.61	0.96	0.32	0.64	1.61	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	50.01	1.72	9.31	2.76	0.00	0.69	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	2.53	10.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	39.43	1.56	1.56	0.67	0.22	0.00	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.32	2.54	5.50	0.42	0.42	1.27	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.52	1.66	6.17	0.71	0.24	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.91	1.72	3.00	0.86	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.99	1.67	2.33	1.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.46	0.90	1.35	1.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	2.78	1.19	0.40	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	36.22	5.57	2.79	0.00	0.00	0.00	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	1.14	2.65	0.38	0.38	0.38	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.77	0.65	2.28	0.98	0.65	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	31.38	1.74	1.74	1.74	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.44	0.90	1.81	1.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	24.69	6.17	4.41	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.24	1.33	5.32	0.66	1.99	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	44.64	1.49	1.98	3.97	0.00	0.00	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.16	3.06	2.68	0.38	0.77	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	52.93	2.42	3.93	0.30	0.91	0.00	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.47	0.66	1.11	0.00	0.00	0.22	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.04	2.03	0.00	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	20.44	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	1.22	2.44	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	30.53	1.89	1.57	1.89	0.00	0.00	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	31.48	0.91	1.51	2.12	0.30	0.30	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	2.37	0.79	0.79	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	38.54	0.00	12.47	2.27	2.27	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	20.23	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	64.85	2.48	1.61	1.37	0.75	0.37	0.12	0.25
Myoblast, donor2	11322-117D8	66.74	1.73	2.30	1.15	0.96	0.96	0.77	0.00
Myoblast, donor3	11398-118D3	64.57	3.70	1.35	0.17	0.67	0.84	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	132.22	2.19	2.92	1.46	0.58	1.31	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	414.53	0.92	6.15	4.92	2.15	4.61	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	340.16	2.11	3.92	3.62	2.41	2.71	4.52	2.71
Natural Killer Cells, donor3	11387-118C1	389.83	1.84	7.91	3.87	1.47	4.42	1.66	1.66
Neural stem cells, donor1	11275-116H6	150.98	1.81	2.54	7.98	0.36	0.36	0.00	0.36
Neural stem cells, donor2	11352-117H2	200.27	0.00	0.00	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	108.10	0.00	2.28	3.41	1.14	2.28	1.14	0.00
Neurons, donor2	11574-120E8	98.19	0.44	1.54	1.10	0.66	0.22	0.44	0.22
Neurons, donor3	11655-122E8	65.77	0.82	4.11	1.64	1.64	2.47	1.64	0.82
Neutrophils, donor1	11233-116C9	171.68	2.78	6.50	6.50	0.93	3.71	0.93	0.00
Neutrophils, donor2	11314-117C9	142.04	2.90	17.39	8.70	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	207.08	6.11	1.22	3.67	0.61	0.61	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	34.31	1.42	0.47	0.36	0.12	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	22.47	2.93	0.65	0.33	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.84	1.60	0.60	0.00	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	74.88	3.72	4.82	1.10	0.28	1.10	1.38	0.41
Olfactory epithelial cells, donor2	11934-125I8	85.25	3.76	5.65	2.03	3.62	0.58	2.75	1.01
Olfactory epithelial cells, donor3	11935-125I9	82.40	2.50	3.41	1.25	0.45	1.48	0.91	0.68
Olfactory epithelial cells, donor4	11936-126A1	75.19	1.85	1.07	1.07	0.58	0.78	0.88	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	33.70	1.20	0.00	0.00	0.60	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	18.08	0.85	0.43	0.21	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	17.15	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	34.76	0.62	1.24	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	41.04	0.39	0.20	0.20	0.00	0.00	0.20	0.39
Osteoblast, donor2	11354-117H4	43.54	0.00	2.11	0.70	0.00	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	32.52	1.07	0.00	0.18	0.00	0.00	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	44.98	0.84	1.01	0.42	0.08	0.42	0.25	0.00
Pericytes, donor1	11491-119E6	30.49	1.67	0.33	0.11	0.33	0.33	0.00	0.00
Pericytes, donor2	11571-120E5	26.26	2.49	1.58	0.23	0.68	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	34.18	1.02	0.81	0.41	0.00	0.20	0.61	0.20
Perineurial Cells, donor1	11499-119F5	69.73	1.92	0.57	0.23	0.57	1.13	0.23	0.00
Perineurial Cells, donor2	11579-120F4	34.32	0.92	0.00	0.18	0.09	0.46	0.00	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	485.44	1.59	4.46	2.55	2.87	3.51	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	283.55	2.69	6.86	1.71	3.18	3.18	6.12	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	343.73	1.55	3.62	1.55	1.81	1.04	2.07	0.91
Placental Epithelial Cells, donor1	11278-116H9	36.11	0.24	0.24	0.00	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	39.92	1.11	2.22	4.44	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	43.39	0.20	0.39	0.20	0.00	0.20	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.65	0.32	0.32	0.32	0.00	0.00	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	58.53	1.31	0.56	3.75	1.13	0.19	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	341.72	4.96	3.52	14.88	1.31	2.22	0.65	0.78
Preadipocyte - breast, donor2	11328-117E5	41.20	0.90	1.13	5.18	1.35	0.45	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	45.18	1.60	0.53	1.39	0.11	0.11	0.11	0.53
Preadipocyte - omental, donor2	11329-117E6	55.00	0.87	0.00	1.75	0.44	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	39.54	0.43	1.00	1.72	0.14	0.43	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	16.73	0.98	0.00	0.00	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	52.52	1.23	0.00	0.00	0.31	0.00	0.00	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	64.28	1.77	1.77	0.89	0.53	1.06	1.06	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	61.47	2.38	1.19	2.55	0.51	0.00	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	72.00	1.30	1.40	1.49	0.37	1.02	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	43.26	1.84	1.38	0.46	0.46	0.46	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	35.63	0.94	0.94	0.63	0.52	0.31	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	63.66	1.96	1.06	0.75	0.75	0.45	0.30	0.45
Prostate Epithelial Cells, donor2	11331-117E8	43.06	4.33	2.03	1.76	0.81	0.41	0.54	0.14
Prostate Epithelial Cells, donor3	11404-118D9	38.46	1.59	1.71	0.73	0.18	0.55	0.55	0.00
Prostate Stromal Cells, donor1	11254-116F3	33.94	0.34	0.23	0.46	0.00	0.46	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	38.73	0.72	1.26	0.90	0.54	0.72	0.90	0.00
Prostate Stromal Cells, donor3	11405-118E1	41.50	0.94	1.04	0.94	0.42	0.31	0.31	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.97	0.36	0.36	1.09	1.09	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.81	0.62	0.49	0.21	0.07	0.55	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	48.69	0.51	0.51	0.00	0.00	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	39.12	1.42	0.00	0.00	0.00	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	64.05	1.27	1.06	0.42	0.74	0.74	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.28	0.68	0.68	0.00	0.00	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.63	0.67	0.40	0.00	0.00	0.00	0.27	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.31	1.11	0.67	1.11	0.22	0.44	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	0.67	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	37.64	2.20	0.22	0.22	0.00	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	31.98	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	32.46	1.11	0.28	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	49.39	1.34	0.27	1.07	0.00	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.04	0.84	0.00	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	46.48	0.58	0.58	0.00	0.00	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	33.71	1.04	0.78	0.26	0.00	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	53.15	2.56	0.57	0.85	0.28	0.57	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	30.87	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	54.20	1.25	0.75	0.50	0.50	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	126.15	2.14	1.34	0.27	0.40	0.27	0.13	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	100.06	1.79	2.68	2.68	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	112.83	1.65	11.01	2.20	1.10	0.55	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	154.87	4.64	5.80	2.32	0.00	0.00	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	72.81	1.56	1.56	1.43	0.13	0.65	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	71.50	1.79	1.89	0.89	0.50	0.30	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	123.59	0.78	2.23	1.34	0.22	0.67	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	65.87	1.12	1.61	1.12	0.62	0.50	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	70.28	1.28	1.17	1.17	0.82	0.47	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	110.94	1.85	3.47	1.62	0.23	0.23	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.23	1.10	0.55	1.51	0.55	0.41	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	77.30	0.76	1.66	0.30	0.45	0.30	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	82.79	1.43	0.90	1.08	0.36	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.27	1.15	2.44	0.43	0.72	0.29	0.57	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	66.86	0.64	1.72	0.54	0.32	0.32	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	108.20	1.33	3.32	0.89	0.22	0.89	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	53.15	0.38	1.15	1.34	0.00	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	81.52	1.21	1.02	0.19	0.19	0.56	0.37	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	136.04	2.25	2.63	0.94	0.56	0.94	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	64.89	0.66	1.46	0.27	0.27	0.13	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	84.98	0.88	1.17	0.78	0.39	0.49	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	119.16	1.34	3.82	2.10	0.19	0.57	0.38	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	54.25	0.53	1.17	0.11	0.75	0.00	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	82.41	0.28	0.84	1.40	1.12	1.40	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	122.71	1.54	2.91	1.20	0.85	1.03	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	57.62	0.73	1.09	0.91	0.36	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	95.16	0.86	1.47	0.49	0.25	0.37	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	117.26	1.21	1.34	1.34	1.21	0.67	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	49.06	0.71	1.18	0.94	0.24	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	84.72	0.79	1.79	0.99	0.99	0.40	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	123.00	0.70	3.04	1.17	0.47	1.17	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	52.05	1.24	1.04	1.04	0.83	0.41	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	93.57	0.00	1.99	1.55	1.77	0.22	1.77	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	110.08	1.46	2.30	0.42	0.42	0.21	1.67	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	57.60	2.02	2.29	0.27	0.81	0.40	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	92.81	1.02	0.68	0.34	0.34	0.17	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	115.48	1.74	3.47	0.77	0.39	0.77	1.16	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	54.68	1.55	0.69	0.52	0.17	0.17	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	59.94	1.23	1.10	0.27	0.55	0.14	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	95.55	1.31	3.12	0.66	0.33	0.16	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	54.20	0.85	2.05	1.19	0.68	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	72.65	0.89	1.48	0.44	0.74	0.44	0.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	97.29	1.33	1.60	0.53	0.53	0.53	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	68.44	1.24	1.80	0.83	0.55	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	63.34	0.71	1.43	0.24	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	150.95	3.22	2.62	1.61	0.60	0.81	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	64.04	0.85	2.26	0.66	0.57	0.57	0.09	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	90.48	1.75	2.45	2.45	0.00	0.00	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	94.29	0.00	2.12	0.60	0.00	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	84.32	1.59	2.94	1.10	0.61	0.24	0.24	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	437.09	3.06	5.24	1.75	1.31	1.46	0.58	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	113.78	1.22	3.65	1.22	0.61	0.61	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	64.50	1.21	2.71	0.00	0.60	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	104.50	1.58	6.79	1.36	1.36	1.36	1.13	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	181.52	5.39	7.49	0.60	1.80	1.50	1.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	115.71	1.06	6.61	0.94	0.71	0.47	0.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	141.09	1.49	2.99	1.92	0.43	0.43	1.49	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	199.52	3.61	4.81	4.81	2.40	0.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	25.95	1.50	0.38	0.19	0.38	0.38	0.56	0.00
Schwann Cells, donor2	11578-120F3	27.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	20.16	0.44	0.44	0.44	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	46.56	3.83	0.00	0.55	0.00	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	27.11	0.92	0.92	3.22	0.46	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	27.83	1.24	0.21	0.82	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	44.73	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	64.96	0.00	0.00	8.47	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	59.56	0.53	1.41	0.35	0.18	0.44	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	20.96	0.00	0.00	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	29.26	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	45.40	1.73	0.94	0.79	0.16	0.31	1.10	0.16
Skeletal Muscle Cells, donor5	11455-119A6	36.57	0.89	1.93	0.45	0.15	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	54.02	1.39	0.62	0.46	0.31	0.15	0.92	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	109.50	5.17	1.01	0.88	0.50	0.63	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	69.77	4.28	1.00	0.71	0.43	0.14	1.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.07	1.79	1.79	0.69	0.20	0.50	0.50	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.90	1.10	0.67	0.42	0.25	0.67	0.25	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	0.72	0.00	0.00	0.00	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.63	0.41	0.28	0.00	0.14	0.14	0.41	0.28
Skin - palm, donor1	10286-104F7	354.57	8.06	21.49	0.00	0.00	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.26	0.86	0.86	0.29	0.00	0.14	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	1065.71	36.81	73.61	53.16	30.26	9.00	16.36	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.73	1.56	1.95	0.78	0.26	0.26	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	62.14	1.25	2.22	0.83	0.56	0.56	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	50.36	2.81	0.70	1.13	0.28	0.28	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1230.40	34.68	14.59	39.96	5.92	8.46	2.75	4.02
Small Airway Epithelial Cells, donor3	11406-118E2	54.26	2.02	1.50	1.12	0.37	0.67	0.30	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.33	0.31	0.31	0.00	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	275.69	7.78	5.78	3.56	3.33	2.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.09	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.31	0.88	0.22	0.66	0.00	0.22	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.08	0.39	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	47.90	1.55	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	91.07	1.00	2.00	1.00	3.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.70	0.53	0.00	0.40	0.00	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	58.74	1.33	1.77	1.11	0.44	1.11	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.02	0.77	0.13	0.00	0.00	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	46.89	0.65	0.00	0.65	0.00	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	52.86	1.48	0.89	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	53.10	2.28	0.57	0.71	0.28	0.28	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.47	0.16	0.16	0.16	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.88	1.83	0.91	0.00	0.30	0.30	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	33.84	2.27	0.00	0.51	0.00	0.25	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	19.55	1.43	0.00	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	50.29	0.74	0.88	0.59	0.15	0.44	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.85	1.29	0.65	0.22	0.00	0.22	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.60	0.94	0.94	0.52	0.42	0.63	0.63	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	23.67	0.62	0.00	0.15	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	3.23	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.55	0.30	0.30	0.60	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	44.72	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	101.07	3.61	0.71	0.39	1.10	0.94	0.47	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	61.09	2.42	3.12	2.42	0.70	0.60	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	73.27	1.59	1.37	1.59	1.59	0.68	1.14	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.77	1.32	1.32	0.79	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.09	0.93	1.33	0.93	0.13	0.27	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	44.33	1.75	1.63	1.00	0.63	0.75	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	35.26	0.76	0.76	2.03	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	26.84	0.00	0.15	0.15	0.00	0.15	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	22.51	1.50	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	0.00	2.58	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.16	0.47	0.00	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.43	0.50	0.50	0.50	0.50	0.50	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.61	1.25	0.00	0.00	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	32.15	0.88	0.29	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	27.24	0.50	0.25	0.00	0.00	0.08	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	48.58	2.34	0.47	0.93	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.89	0.43	0.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	33.65	1.02	0.25	0.00	0.00	0.25	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.43	0.00	0.19	0.00	0.00	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.69	1.68	0.56	0.84	0.28	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.60	0.34	0.25	0.25	0.08	0.08	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.06	0.24	0.24	0.00	0.00	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.29	1.10	1.33	1.10	0.66	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.62	0.59	0.29	2.05	0.29	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	59.67	2.72	2.72	0.58	1.36	0.58	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	54.21	0.53	2.91	4.23	0.53	0.26	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	66.95	2.60	2.23	11.16	1.86	1.49	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	81.21	5.03	2.16	7.19	2.52	1.08	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	43.44	0.85	0.85	1.42	0.00	0.85	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.63	0.39	0.79	0.79	1.58	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	65.01	3.30	3.05	7.87	2.79	1.52	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	50.71	4.79	4.79	1.60	0.80	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	45.98	0.42	2.51	1.67	0.84	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	44.00	1.83	1.38	3.21	0.00	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	52.85	0.67	0.84	1.85	0.34	0.50	0.17	0.00
Synoviocyte, donor2	11368-117I9	54.48	0.50	2.35	1.17	0.84	0.84	0.34	0.34
Synoviocyte, donor3	11440-118H9	38.87	0.67	4.02	0.45	0.22	0.45	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	53.60	0.71	0.71	0.00	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	37.97	0.46	0.23	0.00	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	16.99	1.15	0.00	0.14	0.00	0.14	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	27.83	0.39	0.00	0.39	0.00	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	30.35	1.72	0.00	0.00	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	119.21	2.71	2.46	0.37	0.37	0.12	0.37	0.49
Urethra, donor2	10319-105A4	206.82	0.00	21.58	8.99	1.80	0.00	1.80	1.80
Urothelial Cells, donor1	11520-119H8	40.38	1.06	0.53	0.53	0.00	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	31.64	0.80	0.00	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	26.82	1.60	0.23	0.00	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	59.29	3.57	0.67	1.11	0.22	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	224.23	2.67	3.56	1.78	3.56	4.45	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	211.58	4.29	4.29	4.29	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	246.43	0.68	2.74	0.00	4.79	1.37	6.16	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	289.59	2.41	4.82	4.13	2.07	5.51	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	301.55	2.32	4.07	3.49	3.49	3.49	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	231.16	1.04	0.00	5.21	0.00	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	244.13	0.92	1.84	0.00	2.75	3.67	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	262.00	0.91	5.48	1.83	2.74	2.74	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	70.56	3.58	2.10	1.11	0.25	1.11	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	108.24	0.88	1.76	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	74.02	3.07	1.40	0.84	0.28	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	204.59	0.00	6.20	8.27	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	94.33	0.25	4.33	3.57	0.00	2.04	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	99.60	0.23	2.55	0.93	0.46	0.93	0.00	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	217.35	1.42	3.32	3.21	0.95	2.02	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	93.88	1.90	2.45	2.18	0.00	1.09	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	104.56	0.28	4.22	1.69	0.56	0.84	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	111.66	0.21	0.42	1.27	0.42	0.21	0.00	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	307.05	2.99	5.44	8.17	1.91	2.18	1.36	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	97.82	1.32	3.97	0.88	0.44	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	155.58	4.08	6.53	3.27	1.23	0.41	0.82	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	176.29	3.11	5.44	6.99	0.39	1.16	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	85.38	1.29	2.21	1.47	0.55	0.37	0.74	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	343.25	3.90	46.81	3.90	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	82.26	1.16	1.39	0.93	0.23	0.70	0.46	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	171.65	1.55	4.14	2.33	1.04	2.59	1.55	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	109.30	1.75	4.09	1.75	0.88	2.05	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	102.71	2.32	3.72	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	202.75	0.82	6.99	7.81	0.41	0.82	2.88	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	0.61	3.38	0.00	0.00	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	96.86	2.99	2.13	2.13	0.85	1.28	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	88.87	2.43	1.52	1.21	0.30	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	90.51	2.89	1.68	1.20	0.24	0.48	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	63.48	0.67	1.34	1.34	0.22	1.11	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	86.72	0.67	1.67	0.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	150.51	3.72	20.44	1.86	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	116.01	1.51	3.39	2.64	0.00	0.75	0.38	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	157.01	3.05	0.87	0.44	0.00	1.74	2.18	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	262.42	0.00	13.12	3.75	0.00	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	63.11	2.59	1.18	0.00	0.47	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	103.77	0.78	0.16	0.47	0.62	0.16	0.16	0.16
adipose, donor1	10184-103D4	182.96	0.59	25.80	6.45	1.17	1.17	1.76	1.17
adipose, donor2	10185-103D5	154.50	2.43	25.55	4.87	0.41	1.62	1.62	0.00
adipose, donor3	10186-103D6	130.97	3.00	10.89	1.91	1.36	1.63	1.09	0.00
adipose, donor4	10187-103D7	75.41	3.47	10.40	2.60	0.87	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	78.75	4.26	2.05	0.63	0.00	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	98.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	103.92	1.87	0.67	1.07	0.67	0.53	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	69.32	2.50	2.86	1.07	0.71	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	32.69	0.70	0.70	0.70	0.00	0.23	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	28.06	1.01	0.34	1.35	0.00	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	60.39	1.47	1.47	0.59	0.00	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	167.20	2.37	1.19	2.37	2.37	1.19	0.00	2.37
amygdala, adult, donor10252	10151-102I7	354.84	4.46	7.91	4.46	2.03	1.62	2.64	7.91
amygdala, newborn, donor10223	10360-105E9	75.85	2.58	3.87	0.32	0.00	0.00	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	140.44	6.11	1.66	4.33	0.76	0.38	0.00	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	82.29	2.43	2.87	1.32	0.44	0.22	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	498.38	9.35	22.71	5.01	1.34	2.00	1.34	0.33
aorta, adult, pool1	10052-101G7	192.01	1.57	2.75	1.18	1.37	0.20	1.77	0.98
appendix, adult	10189-103D9	342.32	0.39	6.60	6.60	1.55	1.16	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	254.86	9.63	7.91	2.75	2.41	2.06	1.38	1.72
artery, adult	10190-103E1	149.46	0.00	6.79	2.72	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	84.60	0.43	1.30	0.72	0.43	0.29	0.14	0.58
b cell line:RPMI1788	10427-106D4	135.02	1.64	1.34	1.19	0.15	1.64	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	68.81	1.39	1.11	1.66	1.66	0.83	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	84.84	2.08	1.19	1.19	0.20	0.89	0.00	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	66.45	0.33	0.84	1.17	0.17	0.17	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	227.61	7.27	4.47	2.80	0.56	2.80	1.12	0.00
bladder, adult, pool1	10011-101C2	136.02	0.98	1.41	0.98	0.54	0.22	0.76	0.11
blood, adult, pool1	10053-101G8	95.23	2.21	0.00	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	75.36	1.71	5.99	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	119.44	0.67	8.77	3.37	0.67	1.35	0.00	0.67
brain, adult, donor1	10084-102B3	106.61	5.13	3.08	0.00	1.03	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	119.38	1.89	3.79	1.11	0.45	1.00	0.67	1.00
brain, fetal, pool1	10085-102B4	168.30	5.34	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	128.51	1.98	5.62	6.28	0.00	0.33	2.64	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	140.05	5.62	1.12	0.75	0.25	0.50	0.00	1.12
breast, adult, donor1	10080-102A8	45.46	0.00	1.26	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.80	1.40	1.14	0.13	0.25	0.38	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	86.89	2.47	1.86	0.31	0.31	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	152.64	7.37	6.91	4.83	2.30	3.91	2.07	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	55.92	4.36	1.21	0.97	0.00	0.00	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	152.80	7.05	3.76	2.82	0.47	1.88	1.41	0.94
carcinoid cell line:NCI-H727	10735-110B6	114.74	1.97	2.73	0.98	0.44	0.22	0.55	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	110.91	2.54	3.49	2.54	0.95	1.90	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	183.93	2.66	5.32	2.13	0.53	1.33	3.73	0.00
caudate nucleus - adult, donor10196	10177-103C6	211.84	5.76	6.91	3.45	1.15	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	329.13	3.51	5.02	1.67	1.67	1.67	5.69	7.20
caudate nucleus, adult, donor10258	10379-105H1	166.58	2.29	6.11	0.76	5.35	2.29	0.00	3.82
caudate nucleus, newborn, donor10223	10354-105E3	138.07	2.93	5.49	3.66	1.46	0.73	0.73	1.83
cerebellum - adult, donor10196	10173-103C2	541.87	2.91	43.70	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	873.47	3.63	21.14	8.11	3.84	2.78	9.39	4.48
cerebellum, adult, pool1	10083-102B2	180.41	1.38	7.59	2.07	1.72	0.34	2.76	0.00
cerebellum, newborn, donor10223	10357-105E6	506.48	4.98	25.74	17.44	7.47	0.83	9.13	2.49
cerebral meninges, adult	10188-103D8	42.86	0.25	1.26	1.76	0.25	0.00	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	79.67	0.73	10.23	3.65	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	129.84	4.46	1.87	1.01	0.14	0.86	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	123.29	2.82	2.49	0.99	0.50	0.66	0.17	0.83
cervix, adult, pool1	10013-101C4	281.90	0.73	3.57	2.10	1.78	0.73	1.26	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	146.58	1.81	2.79	2.93	0.14	1.53	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	41.80	1.31	2.61	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	121.04	4.23	2.61	1.86	1.37	0.75	0.50	0.50
choriocarcinoma cell line:SCH	10785-110H2	46.94	1.36	1.36	0.99	0.49	0.62	0.12	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	87.99	2.61	3.56	1.66	0.47	0.95	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	35.61	0.57	0.57	1.71	0.28	0.00	0.00	1.99
chorionic membrane cells, donor2	12239-129G7	29.43	0.70	0.00	0.80	0.10	0.10	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	41.76	1.65	2.75	4.40	2.20	0.55	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	64.63	0.00	1.01	4.04	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	145.42	2.11	2.69	1.73	0.77	1.34	0.96	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	168.32	3.80	3.59	2.75	1.69	1.06	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	102.72	4.11	1.28	2.57	0.51	1.28	0.51	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	92.16	3.87	1.45	0.73	0.48	0.48	1.45	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	122.98	4.48	0.20	1.83	0.61	0.61	1.83	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	193.16	4.42	5.89	1.77	0.29	1.18	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	257.50	5.47	2.35	1.56	0.78	1.30	0.78	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	85.26	4.57	3.89	2.06	1.37	0.23	1.83	0.23
clear cell carcinoma cell line:TEN	10636-108I6	34.18	1.74	0.17	1.39	0.35	0.00	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	50.89	0.73	0.55	1.46	0.18	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	151.27	2.28	1.52	1.14	0.38	0.38	0.00	0.38
colon, adult, donor1	10082-102B1	166.60	1.19	1.19	1.19	2.38	0.00	7.14	0.00
colon, adult, pool1	10014-101C5	228.19	1.53	1.18	1.18	0.47	0.71	0.82	0.59
colon, fetal, donor1	10070-101I7	85.28	4.33	4.33	0.62	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	2080.92	0.00	4.58	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	200.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	298.30	1.70	2.97	10.62	0.42	1.27	0.00	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	135.39	3.32	1.66	1.81	1.06	1.51	0.45	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	149.75	2.82	2.26	2.40	0.71	0.56	0.28	0.56
corpus callosum, adult, pool1	10042-101F6	408.75	4.09	2.10	2.54	1.22	1.22	0.22	0.33
cruciate ligament, donor2	10295-104G7	230.98	0.81	8.92	4.86	0.00	0.00	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	103.53	0.00	4.82	4.01	1.61	0.80	0.00	0.80
diencephalon, adult	10193-103E4	71.76	1.44	2.64	1.20	0.48	0.72	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	111.13	0.00	2.30	1.61	1.15	0.00	2.07	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	86.93	1.54	1.28	1.03	0.51	0.51	0.00	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	96.53	2.65	2.17	0.72	0.72	1.20	0.00	0.00
ductus deferens, adult	10196-103E7	341.86	5.48	12.46	5.98	2.99	1.99	4.98	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	191.55	8.64	12.96	0.00	2.88	2.88	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	353.11	5.15	6.62	6.62	3.68	2.94	2.94	1.47
dura mater, adult, donor1	10041-101F5	324.40	2.73	1.40	1.24	0.66	0.99	0.58	1.32
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	122.58	1.33	1.11	4.66	0.44	0.67	0.00	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	88.41	0.57	1.29	2.15	0.29	0.43	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	44.40	1.85	0.00	0.00	0.00	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	43.59	2.12	0.30	0.30	0.30	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	56.19	1.54	0.62	0.93	0.31	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	53.85	0.00	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	107.93	4.36	4.69	1.34	0.67	0.67	0.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	80.47	2.54	3.26	1.99	0.54	0.91	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.06	1.13	0.96	0.96	0.64	0.32	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	52.24	2.00	0.56	0.44	0.11	0.22	0.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	76.11	3.63	0.00	0.66	0.11	0.44	0.00	0.11
epididymis, adult	10197-103E8	416.11	4.81	13.81	13.40	1.88	1.88	4.81	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	82.50	2.31	3.90	1.06	0.18	1.06	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.95	1.97	0.79	1.57	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	46.78	2.36	0.52	0.26	0.92	0.66	0.92	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	53.54	3.35	0.79	0.39	0.30	0.10	0.39	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	43.24	2.35	0.78	0.56	0.22	0.22	0.34	0.00
esophagus, adult, pool1	10015-101C6	98.85	0.96	0.85	0.74	0.64	0.11	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	177.46	2.63	1.75	0.75	0.63	1.00	0.00	0.50
eye - muscle inferior rectus, donor1	10272-104E2	294.58	2.41	53.12	14.49	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	122.04	0.00	8.42	6.31	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	150.31	1.49	14.88	5.95	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	227.01	0.00	10.32	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	451.79	4.37	43.72	4.37	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	106.27	5.08	4.32	0.51	1.78	0.76	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	52.44	2.18	1.92	0.77	0.26	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	44.16	0.95	1.19	0.47	0.00	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	233.90	1.88	2.16	0.94	0.56	0.66	0.28	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	139.62	4.50	6.61	4.20	0.30	1.80	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	114.30	7.77	0.55	1.10	0.55	0.64	0.27	0.00
gall bladder, adult	10198-103E9	232.74	3.62	3.14	1.45	0.48	0.72	2.90	0.97
gamma delta positive T cells, donor1	11937-126A2	290.98	0.54	4.83	4.83	1.61	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	211.40	1.49	1.49	8.22	1.49	0.37	1.87	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	75.62	2.53	3.17	1.06	1.06	0.42	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	100.77	2.51	1.55	0.19	0.00	0.58	0.58	0.58
gastric cancer cell line:AZ521	10549-107H9	138.21	3.12	2.62	1.31	0.49	0.98	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	95.18	2.75	1.83	0.92	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	203.56	2.06	4.11	3.43	1.14	0.91	3.20	0.69
giant cell carcinoma cell line:LU65	10487-107B1	106.02	2.29	2.29	1.15	1.26	0.46	0.46	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	83.42	0.98	1.26	0.42	0.14	0.56	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	84.05	2.24	2.99	2.24	0.50	1.25	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	139.43	7.92	3.48	1.37	0.21	1.48	0.32	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	121.20	7.30	3.37	2.39	0.70	1.26	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	90.17	2.76	1.66	1.32	0.77	0.66	0.22	0.00
glioma cell line:GI-1	10413-106B8	151.12	2.93	2.64	0.88	0.59	0.29	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	161.82	2.92	13.12	3.64	1.46	0.00	0.00	2.92
globus pallidus, adult, donor10252	10161-103A8	475.98	5.37	13.18	3.91	2.69	1.22	3.91	3.17
globus pallidus, adult, donor10258	10367-105F7	269.73	2.74	43.81	4.11	2.74	4.11	8.22	0.00
globus pallidus, newborn, donor10223	10364-105F4	96.99	2.13	5.86	1.07	0.00	0.53	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	1558.83	17.13	4.89	2.45	2.45	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	72.32	1.92	1.28	0.64	0.96	0.64	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	39.94	0.92	2.75	0.92	0.46	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	53.04	0.91	0.46	0.91	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	36.07	1.93	1.93	1.29	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	30.18	1.44	2.87	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	21.26	0.69	4.12	0.00	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	103.73	0.00	2.21	1.10	1.10	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	83.33	1.15	1.44	2.01	0.57	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	198.81	1.49	2.69	2.69	1.20	0.90	1.79	0.90
heart - pulmonic valve, adult	10206-103F8	246.05	0.78	11.77	4.18	0.52	1.57	2.61	0.52
heart - tricuspid valve, adult	10207-103F9	155.70	0.00	10.82	1.67	0.83	0.83	0.83	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	84.28	1.43	1.84	1.84	0.82	0.82	1.84	1.02
heart, adult, diseased, donor1	10051-101G6	85.17	0.00	1.70	0.85	1.28	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	45.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	187.08	0.92	1.85	1.33	1.03	0.62	0.10	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	107.67	3.09	3.09	2.78	1.23	0.31	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	124.86	0.00	4.76	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	45.75	1.33	0.11	0.33	0.00	0.77	0.55	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	46.36	1.58	1.09	0.24	0.36	0.24	0.36	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	59.52	1.82	1.01	0.71	0.71	0.51	0.51	0.00
hepatoma cell line:Li-7	10484-107A7	23.13	0.11	0.11	0.44	0.11	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	93.06	0.80	1.61	1.61	0.30	1.01	0.20	0.20
hippocampus - adult, donor10196	10169-103B7	172.23	4.73	13.25	2.84	0.00	0.95	0.95	5.68
hippocampus, adult, donor10252	10153-102I9	373.09	3.27	8.57	4.69	3.47	2.25	5.10	6.53
hippocampus, adult, donor10258	10374-105G5	130.96	1.00	6.47	1.49	0.00	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	97.99	3.52	3.52	0.70	0.70	0.00	1.06	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	78.73	0.61	3.66	4.27	1.83	0.61	3.05	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	61.07	1.57	2.55	1.18	1.18	0.20	0.79	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	72.87	1.78	2.79	2.29	0.76	0.76	1.27	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	148.86	6.77	14.66	3.95	2.26	2.82	2.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	176.36	2.32	27.37	6.46	8.26	3.36	8.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	190.18	3.42	6.45	4.56	0.76	1.14	2.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	276.77	4.09	7.30	3.50	2.04	1.46	3.50	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	251.19	5.39	11.42	4.74	2.37	1.29	3.45	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	230.22	1.67	6.26	1.67	0.00	1.25	2.50	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	102.06	0.47	1.89	3.08	0.24	0.71	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	154.93	2.09	6.43	2.41	2.09	0.16	2.25	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	112.44	2.02	2.02	2.69	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	89.35	2.35	3.91	1.25	1.25	0.63	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	86.47	2.46	3.93	1.47	0.98	0.00	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	77.68	1.75	5.24	0.00	1.75	4.36	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	230.05	3.25	13.94	3.82	4.39	2.67	2.29	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	181.84	3.92	8.72	3.92	3.92	1.31	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	168.42	3.50	20.49	5.50	4.50	2.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	317.63	6.78	17.52	5.09	2.64	1.32	4.90	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	300.57	5.91	20.92	6.82	2.73	2.73	6.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	250.90	3.76	14.72	2.51	2.19	1.57	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	145.01	2.61	8.49	1.96	2.61	1.14	1.47	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	142.54	2.90	5.23	2.32	2.32	1.74	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	147.67	2.99	8.37	2.69	1.79	0.90	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	65.95	3.51	3.14	2.40	1.11	2.03	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	71.04	2.00	2.85	1.43	1.43	0.29	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	79.21	1.22	3.67	0.82	0.41	0.82	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	135.55	1.06	6.34	1.76	2.11	1.06	3.52	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	113.71	4.75	10.45	1.58	0.95	1.90	3.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	148.28	2.42	6.96	3.63	2.42	0.30	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	246.15	4.65	5.17	3.10	2.59	1.03	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	213.86	3.32	6.64	3.32	1.99	0.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	228.57	1.28	2.82	2.57	0.77	0.51	2.57	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	114.53	1.79	1.28	2.30	1.28	0.77	2.05	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	160.53	4.54	3.79	4.54	2.27	0.76	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	105.19	1.34	3.70	0.34	1.34	0.67	1.01	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	71.97	3.38	3.14	1.69	0.48	0.24	0.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	57.49	1.34	1.34	2.23	0.89	0.45	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	58.54	2.93	3.90	0.49	1.46	1.46	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	181.84	4.58	11.61	2.75	2.44	1.22	3.06	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	182.18	3.25	13.01	9.76	3.25	3.25	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	189.63	1.32	13.90	3.64	2.32	2.98	4.63	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	271.46	6.57	5.47	2.74	3.83	1.09	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	249.70	4.34	7.60	3.26	4.34	0.72	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	277.22	3.20	7.12	3.91	2.85	2.14	2.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	125.31	3.58	3.58	1.19	2.39	1.19	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	210.59	2.44	7.31	1.35	0.68	0.95	1.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	95.64	2.16	4.04	0.27	1.08	2.16	0.54	0.27
immature langerhans cells, donor1	11904-125F5	116.47	0.48	0.73	0.73	0.00	0.00	0.24	1.21
immature langerhans cells, donor2	11905-125F6	171.10	2.38	1.58	0.00	2.38	0.00	0.79	2.38
insula, adult, pool1	10039-101F3	305.76	3.97	2.46	1.51	0.57	0.85	0.47	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	36.74	6.83	3.25	0.98	0.65	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	90.62	1.50	1.40	1.00	0.40	0.20	0.20	0.20
kidney, fetal, pool1	10045-101F9	224.59	2.26	0.35	0.64	0.64	0.57	0.42	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	125.26	2.56	2.70	1.14	0.57	0.85	0.28	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	64.42	1.24	1.38	3.18	0.83	0.83	1.24	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	65.33	1.65	1.47	1.28	0.18	0.55	0.18	0.00
left atrium, adult, donor1	10079-102A7	23.43	0.00	3.27	1.09	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	17.19	0.51	1.52	0.00	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	92.48	1.92	2.19	0.27	0.00	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	23.71	0.72	0.36	0.00	0.72	0.00	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	24.46	0.00	0.54	1.63	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	26.71	0.49	0.49	0.00	1.21	0.24	0.97	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	60.64	5.23	1.05	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	221.95	5.90	3.66	1.53	0.83	1.18	0.47	1.06
liposarcoma cell line:KMLS-1	10782-110G8	237.60	5.47	6.09	3.91	0.47	1.72	1.25	0.47
liposarcoma cell line:SW 872	10726-110A6	45.08	2.31	1.46	0.49	0.00	0.24	0.49	0.24
liver, adult, pool1	10018-101C9	41.00	0.49	0.49	0.65	0.00	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	34.81	0.00	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	187.82	2.19	9.19	1.60	1.31	0.87	1.31	1.31
locus coeruleus, adult, donor10252	10165-103B3	272.40	3.88	4.98	3.88	2.03	2.21	2.03	1.29
locus coeruleus, adult, donor10258	10375-105G6	130.07	4.80	27.37	3.10	1.97	1.13	2.82	0.28
locus coeruleus, newborn, donor10223	10362-105F2	126.61	1.26	7.99	1.68	0.42	0.84	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	69.89	1.38	1.38	0.42	0.00	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	144.09	15.17	1.38	1.38	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	52.46	1.58	0.79	0.92	0.53	0.13	0.40	0.00
lung, adult, pool1	10019-101D1	136.08	0.83	1.42	0.71	0.47	0.24	0.47	0.12
lung, fetal, donor1	10068-101I5	281.41	1.14	2.28	1.14	0.86	0.29	0.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	111.80	2.29	16.50	1.83	0.92	0.46	0.92	0.46
lymph node, adult, donor1	10077-102A5	67.69	1.89	1.42	0.00	0.47	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	78.47	0.88	2.85	0.22	0.66	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	102.03	0.60	0.75	2.57	0.30	0.60	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	266.74	2.55	5.10	1.70	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	154.51	3.11	3.55	2.22	0.00	0.44	0.44	1.78
mature adipocyte, donor2	12232-129F9	127.84	2.08	1.66	0.62	0.21	0.42	0.00	0.21
mature adipocyte, donor3	12233-129G1	134.18	1.42	0.95	0.24	0.47	0.47	0.24	0.71
mature adipocyte, donor4	12234-129G2	105.02	0.53	0.79	0.26	0.00	0.00	0.26	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	151.77	2.62	0.95	0.71	0.00	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	142.13	1.13	5.64	2.26	0.00	0.00	0.00	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	353.10	3.13	7.91	3.68	2.94	1.66	2.57	12.32
medial frontal gyrus, adult, donor10258	10368-105F8	73.39	1.59	4.13	0.00	1.27	0.95	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	131.78	0.85	4.26	4.26	2.99	0.00	2.56	8.53
medial temporal gyrus - adult, donor10196	10183-103D3	236.76	3.88	8.44	5.74	7.76	6.41	8.10	9.62
medial temporal gyrus, adult, donor10252	10156-103A3	417.02	6.58	10.61	3.18	2.55	2.12	3.61	10.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	107.87	1.93	3.85	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	157.89	28.71	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	137.83	2.15	2.51	1.79	0.72	0.36	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	150.56	1.95	7.79	1.95	0.00	1.95	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	343.36	4.33	5.11	1.70	1.24	0.93	3.25	0.93
medulla oblongata, adult, pool1	10038-101F2	276.80	2.69	2.12	1.31	1.14	0.41	0.33	0.41
medulla oblongata, newborn, donor10223	10361-105F1	142.00	2.08	3.82	2.08	0.69	0.00	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	448.36	12.84	6.86	5.09	3.10	2.88	5.09	0.00
medulloblastoma cell line:ONS-76	10759-110E3	50.62	2.93	0.98	0.98	0.00	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	74.75	2.30	2.16	0.72	0.00	0.29	0.29	0.57
melanoma cell line:G-361	10465-106H6	63.52	1.36	3.53	0.81	0.27	0.81	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	74.35	3.08	1.45	0.90	0.18	0.90	1.45	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	205.31	5.29	8.81	1.76	0.88	1.76	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	163.31	1.81	4.41	4.15	1.04	1.81	1.56	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.90	0.61	0.31	0.15	0.15	0.15	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	60.71	3.45	0.36	1.45	1.09	0.18	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	53.83	1.66	1.66	0.41	0.41	1.24	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.64	0.28	0.42	0.14	0.00	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.56	0.58	0.39	0.39	0.39	0.19	0.58	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	54.14	0.69	2.78	0.00	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	39.30	1.03	0.69	0.51	0.34	0.00	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	62.34	2.19	1.27	0.92	0.46	0.23	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	46.29	0.53	0.40	0.13	0.40	0.53	0.80	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	29.71	0.27	0.81	0.00	0.00	0.27	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	43.53	0.85	1.00	0.28	0.28	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	162.04	5.60	1.65	2.96	0.00	1.65	1.65	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.29	1.80	0.55	0.42	0.14	0.28	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.80	1.40	1.75	1.40	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.45	1.22	0.82	0.61	0.41	0.00	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	135.51	3.59	2.88	2.88	1.80	1.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.35	1.14	0.41	0.52	0.52	0.31	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	107.38	7.52	4.79	3.19	2.28	0.91	0.91	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	39.02	0.00	0.00	1.68	0.00	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	72.18	2.54	1.49	0.90	0.15	0.45	0.75	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	47.00	1.49	0.70	0.35	0.53	0.00	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	135.48	0.37	2.95	2.95	1.10	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	160.25	8.01	6.30	5.72	2.00	0.29	2.58	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	62.31	2.11	1.68	0.42	0.42	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.08	0.46	0.91	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	51.41	1.79	1.02	1.28	0.26	0.26	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	53.40	1.83	0.26	1.31	0.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	52.07	2.16	0.92	1.54	0.62	0.00	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	60.49	0.47	0.94	1.41	0.47	0.94	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	57.88	1.02	1.02	0.00	0.34	0.34	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	50.69	2.75	0.79	0.79	0.79	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	48.19	0.46	1.39	0.46	0.46	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	54.51	2.31	0.87	0.87	0.29	0.29	0.58	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	59.57	1.78	0.45	0.67	0.22	0.00	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.87	1.44	1.44	0.48	1.20	0.72	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	70.40	3.67	0.73	0.00	0.00	0.00	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	59.41	2.01	1.68	0.67	0.67	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	64.68	1.23	2.05	0.41	0.82	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	66.15	2.15	2.58	0.43	1.29	2.58	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	8.20	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	60.09	0.97	0.97	0.32	0.65	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	1.45	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	53.84	2.67	1.60	1.07	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	51.52	0.00	1.64	1.64	0.00	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	51.31	1.94	1.55	0.78	0.78	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	2.10	0.00	6.30	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	41.73	2.98	0.00	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.25	0.59	1.19	1.19	0.59	1.78	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	52.39	2.44	2.44	2.44	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	0.63	1.90	0.63	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	47.94	2.07	1.72	0.69	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	11.98	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	3.44	0.00	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.75	2.04	1.63	1.22	0.00	0.81	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	37.34	1.59	1.59	0.00	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.60	4.13	0.59	0.59	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	39.59	2.49	0.94	0.31	0.31	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	45.45	5.35	2.67	1.34	0.00	1.34	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	1.18	0.00	0.00	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	0.00	5.14	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	39.93	0.69	0.00	0.00	0.69	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	26.72	0.49	0.49	0.49	0.49	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	1.12	0.00	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	0.64	1.27	0.64	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.54	0.00	0.81	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	0.00	0.00	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	0.61	0.61	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	4.52	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	34.59	1.65	0.00	0.82	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.97	1.19	1.39	0.79	0.60	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.56	1.62	0.32	0.32	0.65	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	0.00	2.04	2.04	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	95.94	3.09	1.55	0.77	0.77	0.77	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	104.65	10.39	2.13	1.65	0.47	0.94	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	99.39	6.95	2.32	1.62	0.46	1.62	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	0.00	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	64.22	1.64	2.16	0.51	0.21	0.10	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	45.84	1.59	0.23	0.45	0.00	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	54.27	0.49	0.73	0.24	0.73	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	35.21	1.99	1.55	0.66	0.22	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	62.81	2.10	2.63	0.00	0.53	0.26	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	66.05	4.26	1.87	0.85	0.68	0.17	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	15.67	0.00	0.25	0.76	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	44.31	1.66	1.24	0.21	0.41	0.00	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	17.72	0.66	0.17	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	41.45	1.27	1.63	0.72	0.36	0.18	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	44.76	3.25	1.02	0.68	0.34	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	71.50	4.58	2.80	1.02	0.51	0.25	1.02	0.00
mesothelioma cell line:No36	10857-111G2	35.88	1.30	0.65	0.33	0.33	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	32.79	1.63	1.08	0.81	0.27	0.00	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	158.91	0.19	1.92	2.49	0.00	0.38	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	104.41	0.37	0.85	2.44	0.12	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	139.99	0.72	1.26	2.15	0.18	0.18	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.44	0.33	1.96	4.24	0.33	1.63	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	28.82	1.27	1.06	0.21	0.21	0.85	0.21	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	57.36	0.23	1.61	0.69	0.69	0.23	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	100.47	1.14	2.47	1.14	0.57	0.57	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	76.50	0.74	0.92	2.22	0.18	0.37	0.00	0.00
myeloma cell line:PCM6	10474-106I6	42.70	0.20	0.20	1.58	0.00	0.20	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	86.24	3.04	1.52	2.54	0.51	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	35.89	0.98	0.98	0.39	0.00	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.31	1.00	0.11	0.33	0.22	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	27.80	0.66	0.29	0.15	0.07	0.15	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	37.54	2.21	2.21	1.10	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	130.67	0.92	3.22	2.07	0.46	0.46	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	75.21	0.94	1.12	0.00	0.37	0.37	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	176.94	2.95	4.43	3.59	1.48	0.84	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	246.17	0.37	5.22	2.42	0.56	2.42	0.56	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	323.10	2.14	12.10	4.98	1.66	1.42	4.27	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	183.72	1.58	5.70	3.48	2.06	1.27	2.53	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	74.06	0.00	2.82	1.61	0.40	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	105.54	3.18	5.72	0.64	0.00	1.27	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	56.16	1.33	1.86	1.33	0.27	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	267.75	14.87	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	411.47	2.20	4.74	6.43	1.52	3.38	1.35	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	72.05	4.80	0.00	0.80	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	73.10	0.96	1.92	2.24	0.64	1.28	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.41	2.10	3.15	4.47	1.58	2.36	1.58	0.26
nucleus accumbens, adult, pool1	10037-101F1	230.88	1.69	1.22	1.03	0.75	0.47	0.09	3.09
occipital cortex - adult, donor10196	10172-103C1	243.13	0.00	6.18	4.12	4.12	0.00	2.06	14.42
occipital cortex, adult, donor10252	10163-103B1	506.94	4.83	20.40	6.98	4.29	4.03	3.76	9.93
occipital cortex, newborn, donor10223	10355-105E4	170.33	2.91	2.91	0.73	1.46	0.00	1.82	4.00
occipital lobe, adult, donor1	10076-102A4	98.92	1.57	3.41	1.31	0.26	0.00	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	182.80	2.15	6.87	4.72	0.86	0.43	1.29	0.43
occipital pole, adult, pool1	10036-101E9	141.84	0.71	0.71	0.55	0.47	0.55	0.08	0.63
olfactory region, adult	10195-103E6	185.51	2.29	8.98	2.87	0.76	1.15	0.57	2.29
optic nerve, donor1	10277-104E7	300.16	8.00	16.01	10.01	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	62.08	5.13	1.25	0.57	0.23	0.23	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.69	3.57	0.41	0.55	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	76.03	1.86	1.69	0.68	0.51	0.34	1.69	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	52.90	1.16	0.58	0.46	0.23	0.35	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	62.32	1.47	1.47	0.59	0.00	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	119.59	4.67	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	183.01	1.48	3.61	1.27	1.27	2.12	0.21	0.00
ovary, adult, pool1	10020-101D2	121.68	0.52	2.18	0.44	0.52	0.26	0.26	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	46.38	2.38	2.20	0.92	0.00	0.18	0.37	0.18
pancreas, adult, donor1	10049-101G4	152.38	1.88	2.82	0.94	0.94	0.00	4.70	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	82.46	5.31	5.31	1.12	0.28	0.28	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	115.50	3.41	2.21	2.04	1.19	1.02	1.53	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	116.74	2.48	1.49	0.99	0.50	0.17	0.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	147.44	1.92	0.73	0.46	0.46	0.55	0.18	2.75
parietal cortex, adult, donor10258	10373-105G4	121.85	0.73	3.67	2.94	1.47	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	191.86	4.70	15.05	3.76	0.94	0.00	1.88	3.76
parietal lobe, adult, donor10252	10157-103A4	364.28	3.14	9.41	6.27	3.14	2.00	3.42	14.82
parietal lobe, adult, pool1	10034-101E7	193.25	2.20	1.32	0.88	1.06	0.53	0.35	2.47
parietal lobe, fetal, donor1	10072-101I9	214.33	3.88	13.58	5.82	3.88	0.00	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	145.06	1.87	3.74	2.24	0.75	0.37	1.87	4.11
parotid gland, adult	10199-103F1	64.13	0.62	0.00	1.23	1.85	0.00	1.23	0.00
penis, adult	10200-103F2	177.25	0.54	9.67	4.83	2.15	0.54	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	104.12	1.30	3.16	2.42	1.12	0.93	1.49	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.92	1.02	0.73	0.58	0.29	0.44	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	370.25	9.68	29.67	9.68	1.29	1.94	0.00	3.87
pineal gland, adult, donor10252	10160-103A7	676.31	26.65	14.21	2.96	0.59	1.18	0.59	7.70
pineal gland, adult, donor10258	10377-105G8	280.30	8.78	16.30	3.76	2.51	0.63	0.00	2.51
pituitary gland - adult, donor10196	10180-103C9	390.56	2.02	21.25	6.07	6.07	0.00	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	525.87	2.61	9.90	2.08	3.13	1.56	1.56	2.61
pituitary gland, adult, donor10258	10378-105G9	206.85	0.00	16.17	5.96	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	155.23	1.83	1.72	0.65	0.22	0.22	0.43	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	113.89	0.53	2.25	0.40	0.40	0.40	0.93	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	74.08	1.71	0.31	4.51	0.62	1.40	0.31	0.00
pons, adult, pool1	10033-101E6	196.58	2.15	1.46	1.64	0.43	0.77	0.26	0.52
postcentral gyrus, adult, pool1	10032-101E5	162.32	2.01	0.87	0.35	0.70	0.44	0.17	2.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	315.80	4.18	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	52.73	5.54	2.04	0.58	0.87	0.87	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	107.09	6.35	3.09	0.73	0.36	1.82	0.00	0.00
prostate, adult, pool1	10022-101D4	147.01	1.18	1.18	0.73	0.45	0.27	0.18	0.45
putamen, adult, donor10196	10176-103C5	277.85	3.54	6.14	2.36	2.60	1.18	4.49	4.96
putamen, adult, donor10252	10152-102I8	286.27	5.88	0.00	25.49	1.96	9.80	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	54.64	1.09	2.19	1.09	2.19	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	113.80	1.45	3.14	0.97	0.97	0.97	0.24	0.48
putamen, newborn, donor10223	10365-105F5	138.69	0.75	9.75	2.25	2.25	1.50	0.75	4.50
rectal cancer cell line:TT1TKB	10469-106I1	47.71	2.04	1.75	0.29	0.00	0.58	0.00	0.29
rectum, fetal, donor1	10067-101I4	190.57	2.78	6.95	0.00	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	140.98	5.72	2.33	6.57	0.21	1.27	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	139.59	15.74	7.87	10.36	2.07	2.49	0.41	0.00
retina, adult, pool1	10030-101E3	375.83	5.96	4.17	3.48	1.89	1.09	1.39	0.20
retinoblastoma cell line:Y79	10475-106I7	262.66	8.83	8.57	6.75	0.52	1.30	0.26	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	106.47	4.06	3.32	0.98	0.12	0.37	0.12	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	113.32	1.12	2.81	1.97	0.28	0.56	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	106.10	3.79	3.03	0.76	0.00	0.00	0.00	1.52
salivary acinar cells, donor1	11771-123I7	106.02	6.80	4.21	1.29	0.16	0.16	0.32	0.16
salivary acinar cells, donor2	11772-123I8	134.25	5.51	2.75	0.83	0.83	0.41	1.65	0.14
salivary acinar cells, donor3	11773-123I9	137.71	10.59	4.63	1.32	0.00	1.32	0.66	1.32
salivary gland, adult, pool1	10093-102C3	143.56	0.57	1.14	1.14	0.00	0.57	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	63.15	2.28	1.01	0.59	0.34	0.67	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	55.95	2.12	1.29	0.71	0.00	0.35	0.00	0.12
seminal vesicle, adult	10201-103F3	367.18	5.29	19.58	14.28	3.17	2.12	7.41	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	195.80	4.37	5.10	1.94	1.70	0.97	3.89	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	85.55	0.75	0.75	1.51	0.50	0.50	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	40.14	2.01	1.00	1.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	74.82	0.67	1.34	0.81	0.40	0.54	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	96.38	0.66	1.11	2.10	0.22	0.44	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	45.16	2.45	0.77	0.52	0.39	0.39	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	131.94	0.00	10.64	7.80	2.84	0.00	2.84	0.00
skeletal muscle, adult, pool1	10023-101D5	68.00	0.24	1.44	0.48	0.12	0.00	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	29.15	1.01	3.02	2.01	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	165.38	1.89	8.84	5.68	1.26	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	151.42	5.67	5.00	2.00	0.67	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	173.36	2.84	8.51	2.21	1.58	0.95	3.78	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	338.85	10.60	9.83	6.55	1.73	1.93	2.31	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	68.40	1.48	0.82	0.49	0.66	0.49	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	322.34	4.18	8.85	1.93	2.09	1.13	1.93	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	158.43	0.87	3.27	2.83	0.00	0.44	0.00	0.87
small intestine, adult, pool1	10024-101D6	227.78	2.63	3.46	1.91	0.84	0.48	0.00	0.96
small intestine, fetal, donor1	10064-101I1	93.86	0.98	4.91	1.23	0.49	0.25	1.97	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	195.42	3.59	3.08	6.15	3.59	1.54	5.64	0.00
smooth muscle, adult, pool1	10048-101G3	187.12	0.26	2.33	2.07	1.03	0.78	2.84	0.78
somatostatinoma cell line:QGP-1	10781-110G7	84.96	1.07	2.14	0.27	0.27	0.00	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	203.48	3.90	9.64	2.06	2.29	0.46	2.75	1.61
spinal cord, adult, donor10252	10159-103A6	292.94	4.34	7.49	1.97	1.58	1.97	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	130.06	2.77	11.07	2.77	3.46	2.77	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	168.92	2.44	5.49	1.22	1.83	2.44	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	224.55	1.38	8.73	3.21	1.38	2.30	2.76	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	62.73	1.19	1.34	0.75	0.30	0.60	0.30	0.30
spleen, adult, pool1	10025-101D7	110.68	0.88	2.64	0.55	0.33	0.22	0.33	0.11
spleen, fetal, pool1	10044-101F8	256.72	1.43	0.87	1.03	0.87	0.32	0.87	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	118.83	3.00	1.35	0.52	0.31	0.83	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.29	1.14	0.76	1.33	0.00	0.76	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	124.41	0.70	3.49	2.45	1.75	2.10	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	82.88	3.52	2.35	0.78	0.00	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	124.04	2.25	2.14	3.15	0.23	0.90	0.00	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.90	0.85	0.00	0.42	0.00	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	90.96	4.23	0.85	0.85	0.42	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	268.06	5.34	11.75	4.27	1.07	0.00	2.14	1.07
submaxillary gland, adult	10202-103F4	252.37	1.71	5.13	6.27	2.85	0.00	2.85	1.14
substantia nigra - adult, donor10196	10178-103C7	488.47	0.00	651.29	162.82	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	384.88	7.48	7.48	3.32	3.74	3.12	2.28	1.25
substantia nigra, adult, donor10258	10371-105G2	117.93	0.52	2.59	2.07	0.52	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	128.60	2.12	7.77	1.41	0.00	1.41	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	149.02	4.13	4.59	4.59	0.23	1.15	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	185.31	2.46	1.10	0.93	0.68	0.51	0.08	2.29
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	193.02	3.56	12.82	9.26	2.14	1.42	0.71	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	227.68	2.20	4.40	7.91	2.20	1.76	3.52	0.88
tenocyte, donor1	11763-123H8	81.34	2.44	1.75	2.79	2.44	1.40	0.00	0.00
tenocyte, donor2	11765-123I1	88.51	4.96	1.53	1.14	0.38	0.38	1.14	0.76
tenocyte, donor3	11768-123I4	107.49	2.59	5.56	4.08	0.74	2.22	0.00	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	78.69	3.40	3.40	1.53	0.17	1.02	0.17	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	67.98	0.92	2.77	0.62	0.31	0.77	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	83.69	1.08	2.79	0.77	0.00	0.31	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	78.07	5.46	2.92	1.40	0.76	0.25	0.25	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	48.03	4.54	1.13	0.00	0.00	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.05	4.91	0.98	1.20	0.22	0.44	0.55	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	90.22	3.58	1.95	2.28	1.30	1.30	2.93	0.00
testis, adult, pool1	10026-101D8	98.35	4.51	3.22	1.18	0.54	0.21	0.64	0.43
testis, adult, pool2	10096-102C6	201.63	16.69	4.96	1.35	1.80	0.45	1.80	0.90
thalamus - adult, donor10196	10168-103B6	198.72	4.42	19.87	5.52	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	460.88	3.91	6.10	3.75	2.50	2.66	2.66	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	83.14	4.62	6.16	1.54	3.08	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	97.50	2.80	21.24	2.64	2.47	1.32	2.64	0.16
thalamus, newborn, donor10223	10366-105F6	44.30	1.73	2.88	1.15	0.58	0.00	0.58	0.58
throat, adult	10209-103G2	219.71	2.50	6.24	3.25	1.00	0.75	1.00	0.00
throat, fetal, donor1	10061-101H7	121.88	2.74	4.27	0.30	1.22	0.00	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	81.28	14.71	3.58	0.79	0.20	0.99	0.99	0.20
thymus, adult, pool1	10027-101D9	164.83	0.30	2.09	0.50	0.20	0.10	0.80	0.10
thymus, fetal, pool1	10043-101F7	479.21	1.87	5.30	3.01	1.97	0.52	1.14	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	65.95	1.86	2.53	1.06	0.93	0.80	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	173.91	2.10	6.01	1.54	0.56	1.40	0.42	0.28
thyroid, adult, pool1	10028-101E1	116.27	1.03	1.59	0.93	0.47	0.28	0.65	0.09
thyroid, fetal, donor1	10060-101H6	206.98	3.16	10.28	1.85	0.79	1.05	2.37	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	326.44	6.16	24.64	3.08	6.16	0.00	6.16	3.08
tongue, adult	10203-103F5	99.78	1.63	1.40	1.86	0.70	0.23	3.02	0.00
tongue, fetal, donor1	10059-101H5	46.11	0.00	2.76	0.39	0.39	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	251.74	1.30	1.10	1.80	0.90	0.40	0.40	0.50
trachea, adult, pool1	10029-101E2	113.05	1.23	0.82	0.90	0.49	0.41	0.49	0.49
trachea, fetal, donor1	10058-101H4	108.48	0.77	4.23	1.54	0.38	0.00	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	55.62	0.35	2.83	1.42	0.35	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	86.42	1.82	0.81	1.32	0.10	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	67.53	2.98	3.76	0.63	0.63	0.94	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	62.78	1.90	7.61	3.81	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	61.12	1.10	1.27	0.51	0.17	0.17	0.25	0.00
umbilical cord, fetal, donor1	10057-101H3	85.55	0.00	8.35	2.09	0.00	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	272.66	1.54	3.07	1.02	0.85	0.34	0.85	2.05
uterus, fetal, donor1	10055-101H1	109.04	1.54	3.58	1.02	0.51	0.51	0.51	0.51
vagina, adult	10204-103F6	100.16	0.00	0.00	0.65	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	208.90	0.88	3.29	2.85	0.66	0.88	3.29	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	96.67	1.87	0.53	1.07	0.80	1.87	0.00	0.27